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81 Introduction
Type 2 diabetes (T2D) is a heterogeneous disorder of carbohydrate, lipid 
and protein metabolism. Th is chronic progressive disease results from 
complex interactions between genetics and early life and adult environ-
mental infl uences. It is characterized by resistance to insulin-mediated glu-
cose disposal in muscle and adipose tissue, failure of β-cells to compensate 
for this resistance and overproduction of glucose in the liver.
Both prevalence and incidence rates of T2D have been increasing world-
wide over the past decades. As the genetic constitution of man has not 
changed rapidly enough to explain the diabetes epidemic, lifestyle-related 
factors seem to have a major impact. Th e imbalance between energy intake 
and energy expenditure, leading to obesity, is an important determinant 
of T2D. In addition, changes in the composition of the diet and interac-
tions between genes and diet may play a role. Modern diets are low in n–3 
fatty acids, antioxidative nutrients (e.g., carotenoids and vitamin E) and 
fi bre compared with ancient diets (Arab 2003, Simopoulos 2003, Cordain 
et al. 2005). Th e nutritional patterns in contemporary affl  uent nations may 
thus be poorly compatible with the older genome, thus contributing to the 
development of lifestyle-related diseases (Simopoulos 2003, Cordain et al. 
2005). 
Although T2D may be largely preventable through lifestyle interven-
tion (Pan et al. 1997b, Tuomilehto et al. 2001, Knowler et al. 2002), the 
prevailing knowledge of the roles of many dietary components as risk or 
protective factors in the aetiology of T2D is contradictory. One underlying 
factor causing discrepancy in results may be genetic heterogeneity among 
study populations. Evidence on nutrient-gene interactions in relation to 
glucose metabolism is scarce. Increased understanding of dietary determi-
nants of glucose metabolism as well as recognition of underlying interac-
tions between genetic and dietary infl uences is crucial for the development 
of eff ective dietary prevention strategies to slow and reverse the disturbing 
T2D trends.
Peroxisome proliferator-activated receptors (PPARs) have recently 
emerged as one group of central regulators of nutrient-gene interactions. 
Th ey belong to the nuclear hormone receptor superfamily and regulate 
genes controlling lipid and glucose metabolism as well as adipogenesis. 
Th e fact that structurally diverse fatty acids can act as ligands of nuclear 
receptors provides a direct link between the availability of fatty acids and 
gene expression. One of the PPAR subtypes, PPAR-γ, regulates the expres-
sion of an array of genes involved in adipocyte diff erentiation, lipid stor-
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9age and insulin sensitization. Currently, one of the most consistent genetic 
predictors of T2D is a common variant in the PPAR-γ2 isoform, which 
results in the substitution of an alanine for a proline at amino acid 12, 
producing Pro12Ala (Yen et al. 1997, Lohmueller et al. 2003). Studies on 
interactions between the Pro12Ala polymorphism and dietary fatty acids 
in glucose metabolism are thus far limited, but suggest an important role 
for this polymorphism in modulating the metabolic response to fatty acids 
(Luan et al. 2001, Robitaille et al. 2003, Pisabarro et al. 2004).
In this study, associations of dietary and plasma cholesterol ester fatty 
acids as well as those of dietary and plasma tocopherols and carotenoids 
and dietary fi bre with glucose metabolism were examined in a high-risk 
population for T2D, i.e., in non-diabetic relatives of aff ected patients. 
Interactions between fatty acids and the Pro12Ala polymorphism of the 
PPAR-γ2 gene in glucose metabolism were also investigated.
1 Introduction
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2 Review of the Literature
Diabetes mellitus is a phenotypically heterogeneous metabolic disease of 
complex aetiology, characterized by chronic hyperglycaemia (Alberti and 
Zimmet 1998). In addition to impaired carbohydrate metabolism, diabetes 
is associated with alterations in fat and protein metabolism.
Th e diagnosis of diabetes is based on blood glucose levels in the fasting 
state and at the 2-h time point during a standardized oral glucose toler-
ance test (OGTT) (Alberti and Zimmet 1998, World Health Organization 
1999). According to the latest WHO criteria, diabetes is classifi ed into four 
distinct types: types 1 and 2 (until recently, referred to as insulin-depend-
ent and non-insulin-dependent diabetes, respectively), gestational diabetes 
mellitus and other specifi c types (Alberti and Zimmet 1998, World Health 
Organization 1999). Besides diabetes diagnosis, two pre-diabetic states, 
impaired glucose tolerance (IGT) and impaired fasting glucose (IFG), are 
defi ned. IGT represents hyperglycaemia with glucose values intermediate 
between normal and diabetic following a glucose load. IFG refers to el-
evated fasting glucose concentrations, which while not meeting the criteria 
for diabetes, are too high to be considered normal. Both IGT and IFG are 
associated with increased risk of future diabetes (Edelstein et al. 1997, Al-
berti and Zimmet 1998).
Of the two main diabetes types, type 1 develops due to autoimmune-
mediated destruction of pancreatic β-cells, resulting in absolute insulin 
defi ciency (Alberti and Zimmet 1998). Type 2 diabetes is characterized 
by insulin resistance and abnormal insulin secretion (Alberti and Zimmet 
1998). Some of the specifi c subtypes of diabetes, such as maturity-onset 
diabetes of the young, are monogenic (Hattersley 1998, Hansen and Ped-
ersen 2005), but mostly the pathogenesis involves multiple genes, environ-
mental triggers and interactions between these (Groop and Tuomi 1997, 
McCarthy 2004). Th e following text deals only with type 2 diabetes.
2.1 Type 2 diabetes – an increasing health problem
worldwide
Rising incidence and prevalence of type 2 diabetes
Globally, T2D accounts for about 90% of all diabetes cases (Stumvoll et al. 
2005). In 1995, the prevalence of diabetes (all types) among the adult pop-
ulation aged ≥ 20 years was estimated to have been about 4% worldwide 
(King et al. 1998). In high-risk groups in Western countries, the prevalence 
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may reach 20%, and even higher fi gures have been found in some ethnic 
groups in North America and the Pacifi c Islands (Steyn et al. 2004). Th e 
prevalence and incidence rates of T2D have been increasing throughout 
the world during the past decades to epidemic proportions (Zimmet et al. 
2001).
In 1995, the number of adults aged ≥ 20 years with diabetes was esti-
mated to have been 135 million globally, and the fi gure was predicted to 
more than double from 1995 to 2025 to reach 300 million (King et al. 1998). 
According to another recent report, the estimates of subjects with diabetes 
were 171 million in 2000 and 366 million in 2030 (Wild et al. 2004). Th ese 
fi gures are, however, based solely upon aging of the populations, and the 
increasing prevalence of obesity is likely to increase the estimates.
Th e number of subjects with T2D was over 160 000 in Finland in 2004 
based on the Social Insurance Institution’s nationwide register on reim-
bursement for diabetes medication (Klaukka 2005). Th e proportional in-
crease from the year 2003 was 5.7%. According to King et al. (1998), the 
number of adults with diabetes, including both known and undiagnosed 
cases, in Finland in 1995 was 300 000, and the estimation for 2025 was 
454 000. However, based on a recent Finnish cross-sectional population-
based survey among subjects aged 45-74 years, the total prevalence of T2D, 
including both previously diagnosed cases and those detected at screening, 
was 16% in men and 11% in women (Peltonen et al. 2006). Th e prevalence 
of abnormal glucose tolerance, also including IFG and IGT, was 42% in 
men and 33% in women.
Until recent decades, T2D was a disease of the middle-aged and eld-
erly. An emerging public health concern is the appearance of IGT and T2D 
among overweight children and adolescents, especially in high-risk popu-
lations (Rosenbloom et al. 1999, Fagot-Campagna et al. 2001). For example, 
in a multi-ethnic cohort of obese American children aged 4-10 years and 
adolescents aged 11-18 years with a body mass index (BMI) over 30 kg/m2, 
IGT was diagnosed in 25% of children and 21% of adolescents (Sinha et 
al. 2002). Of the obese adolescents, 4% had silent T2D. Available data on 
the prevalence of T2D in European Caucasian children and adolescents 
suggest that the problem may be milder than in North America or in other 
races, but nevertheless more serious than thus far thought (Erhardt and 
Molnár 2004, Wiegand et al. 2004). Of Hungarian obese adolescents, for 
instance, ~ 18% had IGT and < 2% had T2D (Erhardt and Molnár 2004). 
Preliminary data show that IGT and T2D have been diagnosed in Finnish 
children as well (Saha et al. 2003).
The burden of type 2 diabetes
Subjects with T2D oft en exhibit an array of associated traits such as hy-
pertension, dyslipidaemia and hypercoagulability. Th ese contribute to 
the vascular complications of the disease, leading to premature morbidity 
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and mortality (Isomaa 2003, Parillo and Riccardi 2004, Steyn et al. 2004). 
Subjects with T2D have a 2- to 4-fold age-adjusted cardiovascular mortal-
ity compared with non-diabetic subjects (Haff ner et al. 1998, Parillo and 
Riccardi 2004). Micro- and macrovascular complications are oft en present 
in individuals with newly diagnosed T2D, indicating that the onset of the 
disease may occur years – up to a decade – before the clinical diagnosis 
(Harris et al. 1992).
Besides human suff ering, the economic burden of T2D and its com-
plications is considerable. Health care systems worldwide will sustain 
enormous costs for the treatment of diabetes and its complications in the 
near future if the ever-increasing number of individuals diagnosed with 
the disease is not halted (Zimmet et al. 2001). Th us, strategies to slow or 
even reverse the escalating epidemic of T2D are clearly needed. Although 
this disease may be largely preventable (Pan et al. 1997b, Tuomilehto et al. 
2001, Knowler et al. 2002), in order to develop the most successful preven-
tive measures, it is essential to gain a more comprehensive understanding 
of the pathogenesis and underlying risk and protective factors. Whether 
dietary modifi cations required diff er, for example, according to the genetic 
susceptibility of subjects remains obscure.
2.2 Metabolic abnormalities of type 2 diabetes
In healthy subjects, blood glucose levels are maintained within a narrow 
range by the coordinated interplay between glucose absorption and uptake, 
metabolism by peripheral tissues and hepatic glucose production (HGP) 
(Saltiel and Kahn 2001). Insulin, which is the main hormone for the regu-
lation of blood glucose, is secreted from pancreatic β-cells in response to 
elevations in blood glucose concentrations, and exerts its eff ects by bind-
ing to and activating a specifi c plasma membrane receptor in peripheral 
target tissues. Insulin promotes glucose uptake in muscle and fat cells by 
stimulating the translocation of insulin-responsive glucose transporter 4 
(GLUT4) from intracellular sites to the cell surface. Subsequently, insulin 
promotes glycolysis as well as storage of glucose and other substrates by 
stimulating glycogen, lipid and protein synthesis. In adipocytes, insulin 
also inhibits lipolysis. In hepatocytes, insulin stimulates lipid and glycogen 
synthesis and inhibits the production and release of glucose by suppressing 
glycogenolysis and gluconeogenesis.
Th e gradual deterioration of glucose homeostasis leading to T2D is 
characterized by an array of metabolic alterations, the main ones being pe-
ripheral insulin resistance, progressive deterioration in β-cell function and 
overproduction of glucose in the liver (Saad et al. 1991, Lillioja et al. 1993, 
Alberti and Zimmet 1998, Kahn 2003, Lyssenko et al. 2005).
132.2 Metabolic abnormalities of type 2 diabetes
2.2.1 Insulin resistance
Insulin resistance is defi ned as a metabolic state in which physiological 
concentrations of insulin produce a subnormal biological response that 
occurs at the level of all insulin-dependent tissues, including, but not lim-
ited to, muscle, adipose tissue and the liver (Caro 1991). As skeletal muscle 
accounts for ~ 80% of insulin-stimulated glucose utilization (Evans et al. 
2004), it has been regarded as the major site of insulin resistance in T2D, 
manifested mainly as reduced non-oxidative glucose disposal (Eriksson 
et al. 1989, Petersen et al. 2004). In adipose tissue, insulin resistance leads 
to an excessive rate of lipolysis and ensuing elevated circulating non-es-
terifi ed fatty acid (NEFA) concentrations (McGarry 2002, Kashyap et al. 
2003). In the liver, glucose output is not suppressed as a result of insulin 
resistance.
Insulin sensitivity is infl uenced by a number of factors, such as age, ge-
netics and the environment, as well as by the interaction between these 
(Groop and Tuomi 1997, Kahn 2003). At least partly lifestyle-determined 
factors known to promote insulin resistance include overall obesity, intra-
abdominal fat accumulation, smoking, physical inactivity and certain di-
etary factors (Facchini et al. 1992, Rönnemaa et al. 1996, Bessesen 2001, 
Kahn 2003, Parillo and Riccardi 2004).
Th e mechanisms for the reduction in insulin sensitivity are not clearly 
understood, but are likely to include impaired access of insulin to skeletal 
muscle due to lowering of blood fl ow or endothelial insulin transport, de-
fects in post-receptor insulin signalling, glucose transport or enzymes reg-
ulating intracellular glucose metabolism and mitochondrial dysfunction 
(Bergman and Ader 2000, Shulman 2000, Clark et al. 2003, Del Prato 2003, 
Petersen et al. 2004, Hansen and Pedersen 2005, Stumvoll et al. 2005). In-
sulin resistance associated with obesity may be caused by an excess pro-
duction by hypertrophic adipocytes of NEFAs, infl ammatory cytokines 
and adipokines (Kahn 2003, Stumvoll et al. 2005).
Insulin resistance is oft en accompanied by a cluster of metabolic ab-
normalities, including, in addition to glucose intolerance, central obesity, 
dyslipidaemia, hypertension, hypercoagulability and microalbuminuria 
(Reaven 1988, Alberti and Zimmet 1998). Th is clustering of risk factors 
is referred to as the ’metabolic syndrome’, ’insulin resistance syndrome’ or 
’syndrome X’ (Reaven 1988, Isomaa 2003).
2.2.2 Impaired β-cell function
Another metabolic abnormality typical of disordered glucose metabolism is 
the deterioration of β-cell function. Th is is manifested as diminution in the 
sensitivity of β-cells to glycaemic stimuli and decreased insulin secretion
(Alberti and Zimmet 1998, Del Prato 2003, Ferrannini et al. 2003). As a re-
sult, insulin responses during OGTT, intravenous glucose tolerance test 
(IVGTT) and hyperglycaemic clamp are delayed and impaired (Eriksson 
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et al. 1989, Pimenta et al. 1995, Vaag et al. 1995, Alberti and Zimmet 1998, 
Kahn 2003).
Proposed mechanisms for diminution of insulin response comprise ge-
netic defects in β-cell mass or function, damage of the secretory process due 
to prolonged exposure to elevated levels of glucose (glucotoxicity) or NEFA 
(lipotoxicity), or both, and amyloid deposition (Evans et al. 2002, El-Assaad 
et al. 2003, Steyn et al. 2004, Stumvoll et al. 2005, Poitout et al. 2006).
Because of the complex and long-lasting disease process through sev-
eral stages, the metabolic pathways and the sequence of underlying defects 
which lead to T2D have remained unclear (Harris et al. 1992, Alberti and 
Zimmet 1998, McGarry 2002). Nevertheless, both insulin resistance and 
defects in insulin secretion are detectable in pre-diabetic states and in sub-
jects with a genetic predisposition to the disease, and they also predict the 
development of clinically overt hyperglycaemia (Eriksson et al. 1989, Lil-
lioja et al. 1993, Vaag et al. 1995, Perseghin et al. 1997, Alberti and Zimmet 
1998, Kahn 2003, Lyssenko et al. 2005). Th e prevailing notion is that insu-
lin resistance is compensated by augmented β-cell function, but if insulin 
resistance is not reversed, a chronically increased insulin demand leads to 
β-cell exhaustion in susceptible individuals, which can result in glucose 
intolerance (Saad et al. 1991, Kahn 2003, Lyssenko et al. 2005). However, 
dysfunction of insulin secretion without impairment of insulin sensitivity 
has been observed in fi rst-degree relatives of subjects with T2D (Pimenta 
et al. 1995). Th e relative contributions of insulin resistance and insulin se-
cretion defects in the pathophysiology of the disease may furthermore dif-
fer according to the ethnic background (Lillioja et al. 1993, Pimenta et al. 
1995, Alberti and Zimmet 1998, Kahn 2003).
2.2.3 Hepatic glucose overproduction
Th e third main metabolic abnormality that characterizes T2D is the over-
production of glucose in the liver as a result of enhanced gluconeogenesis 
(Magnusson et al. 1992). Th is defect has, however, been regarded as a later 
secondary defect, as HGP and its suppression by insulin were normal in 
genetically predisposed twins (Vaag et al. 1995) and fi rst-degree relatives 
of patients with T2D (Eriksson et al. 1989), and as the rate of HGP did not 
predict future T2D (Lillioja et al. 1993). In one study, by contrast, HGP was 
increased in non-diabetic relatives of patients with T2D (Osei 1990).
2.2.4 Disordered fat mobilization and storage
Besides hyperglycaemia, T2D is characterized by abnormal fat storage and 
mobilization, manifested as elevated fasting and post-prandial circulating 
NEFA and triglyceride (TG) levels as well as excessive deposition of fat in 
non-adipose tissues (Cortright et al. 1997, McGarry 2002). Th e failure of 
insulin to suppress lipolysis is observed in subjects genetically predisposed 
to T2D (Lewis et al. 2002), and elevated NEFAs are predictive of deteriora-
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tion in glucose tolerance (Charles et al. 1997). Increased non-adipose tis-
sue fat accumulation characterizes non-obese insulin-resistant off spring of 
parents with diabetes (Jacob et al. 1999, Perseghin et al. 1999).
Th e mechanisms through which excess NEFA concentrations may lead 
to insulin resistance and glucose intolerance are multiple. In 1963, Randle 
et al. proposed the operation of the glucose-fatty acid cycle in muscle cells 
according to which elevated NEFAs induce insulin resistance by competing 
with glucose for oxidation. More recent data have suggested that increased 
concentrations of NEFA may induce insulin resistance via inhibition of 
endothelial insulin transport, defects in insulin signalling and reduced 
skeletal muscle glucose uptake and glycogen synthesis (Dresner et al. 1999, 
Bergman and Ader 2000, Shulman 2000, Saltiel and Kahn 2001).
Acutely, NEFAs have been shown to enhance, but aft er a prolonged ex-
posure to suppress insulin secretion (Grill and Qvigkstad 2000, Kashyap et 
al. 2003, Poitout et al. 2006). NEFAs may also induce β-cell apoptosis (Eitel 
et al. 2002). Increased exposure of the liver to NEFAs increases HGP, leads 
to excessive storage of TGs in liver, increases output of TG-rich very-low-
density lipoproteins and interferes with hepatic insulin clearance, resulting 
in glucose intolerance, hypertriglyceridaemia and hyperinsulinaemia (Berg-
man and Ader 2000, Wajchenberg 2000). Finally, high NEFA may increase 
oxidative stress and activate, for example, the nuclear factor-κB signalling 
pathway, which has been speculated to be involved in the development of 
insulin resistance and impaired insulin secretion (Evans et al. 2002).
In the pathogenesis of T2D, increasing evidence supports a pivotal role 
for abnormal accumulation of TGs, fatty acids and their metabolites in non-
adipose tissues, especially muscle and liver, and also in pancreatic β-cells; 
some data suggest that this might even be the main underlying disorder ex-
plaining both insulin resistance and impaired insulin secretion (Storlien et 
al. 1991, Cortright et al. 1997, Pan et al. 1997a, Grill and Qvigstad 2000, 
Shulman 2000, Wajchenberg 2000, Evans et al. 2002, 2004, Kelley et al. 2002, 
Lewis et al. 2002, Ravussin and Smith 2002, Petersen et al. 2004). Th is abnor-
mality could be a consequence of increased delivery of fatty acids, impaired 
fatty acid oxidation or an imbalance between uptake and oxidation (Cor-
tright et al. 1997, Kelley et al. 2002, Lewis et al. 2002, McGarry 2002).
Adipose tissue regulation of glucose homeostasis
Previously, the main role of white adipose tissue has been thought to be to 
store energy during times of plenty and to release energy during times of 
need. Recently, adipose tissue has been recognized to communicate con-
tinuously with other tissues (Evans et al. 2004). Under hormonal control, 
adipose tissue functions when it responds to insulin by increasing the dif-
ferentiation of pre-adipocytes to adipocytes, by increasing glucose uptake 
and TG synthesis and by inhibiting lipolysis (Evans et al. 2004). As an en-
docrine organ, adipose tissue produces and secretes several hormones and 
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other protein factors called adipokines (Ravussin and Smith 2002, Tray-
hurn and Wood 2004). Th ese include, for example, leptin, tumour necro-
sis factor-α, plasminogen activator inhibitor-I, adiponectin, resistin and 
interleukin-6 (Havel 2002, Ravussin and Smith 2002, Trayhurn and Wood 
2004, Wolf 2004). Th ese factors regulate the function of several other or-
gans and aff ect the metabolism of the body overall (Morrison and Farmer 
2001, Trayhurn and Wood 2004). Leptin reduces food intake and increases 
energy expenditure and insulin sensitivity (Havel 2002). Tumour necrosis 
factor-α aff ects insulin action, e.g., via the inhibition of lipogenesis and 
stimulation of lipolysis, as well as directly by impairing insulin signalling 
(Trayhurn and Wood 2004, Wolf 2004). Plasminogen activator inhibitor-
I is involved in the maintenance of vascular homeostasis (Trayhurn and 
Wood 2004). Adiponectin promotes fatty acid oxidation in skeletal mus-
cle, increases insulin sensitivity and decreases HGP (Havel 2002, Holst and 
Grimaldi 2002). Resistin inhibits the diff erentiation of preadipocytes to 
adipocytes, increases adipose tissue and liver insulin resistance, reduces 
insulin-mediated glucose uptake and increases HGP and glucose levels 
(Wolf 2004). Markers of subclinical infl ammation, such as interleukin-6, 
are elevated in insulin-resistant states and have predicted the development 
of T2D (Pradhan et al. 2001, Hu and Stampfer 2003). Th us, besides the 
deleterious eff ects of increased delivery of NEFAs, excessive adipose tissue 
in obesity may adversely aff ect glucose metabolism through dysregulated 
secretion of adipokines.
2.3 Aetiology of type 2 diabetes
According to the contemporary conceptual framework, T2D is a multifac-
torial disease resulting from a complex interaction between genetics, early 
life and adult environmental factors, leading to the presence of defects of 
glucose homeostasis (Figure 1).
Th e two major hypotheses put forward concerning the aetiology of T2D 
are the ’thrift y genotype’ and the ’thrift y phenotype’. Th e ’thrift y genotype’ hy-
pothesis postulates that humans were programmed during the hunter-gath-
erer era for a thrift y response to energy supply (Neel 1962). Adaptive mecha-
nisms that promoted eff ective energy storage and fat deposition during times 
of plenty and effi  cient use of energy during episodes of food shortage were 
selected to enhance the likelihood of survival (Neel 1962, Lewis et al. 2002). 
Under contemporary affl  uent conditions where energy-dense foods are read-
ily available and do not require signifi cant energy expenditure, these same 
responses have lost their usefulness and may result in obesity and T2D.
Th e ’thrift y phenotype’ hypothesis, which was tendered by Hales and 
Barker (1992), was based on and later further supported by epidemiologi-
cal observations linking low birth weight with the risk of adult disease, 
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including T2D (e.g., Lithell et al. 1996, Ravelli et al. 1998; summarized by 
Phillips 1998 and Steyn et al. 2004). Th e hypothesis proposes that malnu-
trition during critical periods of intrauterine development and early life 
leads to permanent changes in the structure or function, or both, of the de-
veloping systems, a process called programming, which could predispose 
to disease in adult life (Hales and Barker 1992, Ozanne and Hales 1999). 
Regarding T2D, foetal malnutrition would, e.g., lead to decreased β-cell 
mass and reduced insulin secretion (Hales and Barker 1992). Although the 
metabolic adaptations would be benefi cial to survival in poor nutritional 
conditions, long-term modifi cations to organ structure, hormone respon-
siveness or gene expression might be detrimental and predispose to meta-
bolic disorders when nutrition is abundant in later life (Leon 1998, Phillips 
1998, Ozanne and Hales 1999, Simmons 2005).
Th e ’thrift y genotype’ and ’thrift y phenotype’ hypotheses are not neces-
sarily exclusive and may complement each other (Frayling and Hattersley 
2001, Jaquet et al. 2002). A study in twins provided evidence of a role for 
both the intrauterine environment and genetic factors in the aetiology of in-
sulin resistance (Poulsen et al. 2003). Furthermore, genetically determined 
impairment in insulin action or secretion could result in low foetal growth 
and insulin resistance later on (Hattersley and Tooke 1999, Hansen and Ped-
ersen 2005).
Adult
environment 
(e.g., obesity, physical 
inactivity,  
dietary factors) THRIFTY  
GENOTYPE 
Insulin resistance and 
?-cell dysfunction 
Susceptibility  
genes
(e.g., obesity and 
insulin resistance 
genes)
THRIFTY  
PHENOTYPE
TYPE 2 
DIABETES 
Early
environment
(e.g., foetal 
malnutrition) 
Figure 1. Aetiology of T2D (depicted according to Mandrup-Poulsen 1998, Frayling 
and Hattersley 2001, Steyn et al. 2004, Lee et al. 2005).
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Aetiological determinants and risk factors of type 2 diabetes
Aetiological determinants and risk factors that contribute to the develop-
ment of T2D include the following (Zimmet et al. 2001):
Genetic factors
 Genetic markers, family history, ’thrift y gene(s)’
Demographic characteristics
 Sex, age, ethnicity
Behavioural and lifestyle-related risk factors
 Obesity (including distribution of obesity and duration)
 Physical inactivity
 Diet
 Stress
 Westernization, urbanization, modernization
Metabolic determinants and intermediate risk categories of T2D
 IGT
 Insulin resistance
 Pregnancy-related determinants (parity, gestational diabetes, dia-
betes in off spring of women with diabetes during pregnancy, in-
trauterine mal- or overnutrition)
T2D aggregates in families (Yki-Järvinen 1994, Lyssenko et al. 2005). Th is 
is likely to be more the result of genetics than social origin, as monozygotic 
twins show higher concordance rates for the disease than dizygotic twins 
(Newman et al. 1987, Kaprio et al. 1992). In addition, 45% of fi rst-degree 
relatives of patients with T2D are insulin-resistant compared with only 
20% of individuals without a family history of diabetes matched for age and 
BMI (Groop et al. 1996). First-degree relatives also have an increased risk 
of developing the disease compared with the general population (Perseg-
hin et al. 1997, Hansen and Pedersen 2005, Stumvoll et al. 2005). Migration 
studies add further to the evidence that genetic variation contributes to 
individual susceptibility to T2D (McCarthy 2004). Th e role of heredity ap-
pears, however, to diff er between populations and to be dependent on the 
environment (O’Rahilly et al. 2005).
Regarding demographic determinants, the risk of developing T2D is 
known to increase with age (Alberti and Zimmet 1998, Steyn et al. 2004), 
and persons from certain ethnic backgrounds, such as African-Ameri-
cans, Hispanics and Native Americans, are at greater risk than Caucasians 
(Haff ner 1998, Steyn et al. 2004). Some fi ndings suggest that women have 
a greater risk (Rosenbloom et al. 1999), although the sex diff erence may 
be explained by diff erences in, for instance, obesity and physical activity 
(Steyn et al. 2004).
Th e prevailing epidemic of T2D has arisen only over the past decades, 
and thus, cannot be due to changes in the human genome. Instead it refl ects 
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marked changes in environmental factors, the importance of which in the 
pathogenesis of T2D is supported by not all monozygotic twins being con-
cordant for the disease (Newman et al. 1987, Medici et al. 1999). Observa-
tions in twins have also shown that non-genetic components contribute 
to all three major metabolic abnormalities of T2D, i.e., insulin resistance, 
impaired insulin secretion and elevated HGP (Vaag et al. 1995).
2.3.1 Genetic factors
Th e factors and the extent to which they are inherited in T2D are largely 
obscure. Nevertheless, the disease is known to be complex, and a number 
of genes are likely to be involved, each with modest eff ects (Kadowaki et 
al. 2003, McCarthy 2004). Th ese may include, but are not necessarily lim-
ited to, genes encoding for proteins that are involved in β-cell, myocyte, 
adipocyte and/or hepatocyte development and function, insulin signalling, 
intermediary metabolism or hypothalamic regulation (Saltiel and Kahn 
2001, McCarthy 2004). Both insulin sensitivity and insulin secretion are 
partly under genetic control (Vauhkonen et al. 1998, Lehtovirta et al. 2000, 
Hansen and Pedersen 2005).
Recent advancements in genomic research and statistical methods have 
enabled attempts to unravel genetic variants that infl uence T2D-related 
traits and predispose to the disease. Th e candidate gene approach examines 
a priori selected genes with either an identifi ed or a suspected role in the 
disease process, while the genome-wide scan or linkage analysis refers to 
the systematic screening of the entire genome to identify novel genes that 
infl uence the phenotype of interest (Stumvoll et al. 2005).
Over the past years, several genes regulating fat storage and distribution, 
NEFA metabolism, fuel oxidation and skeletal muscle glucose metabolism 
have been investigated for their potential role in T2D, but no genetic locus 
accounting for the disease has been found (Isomaa 2003). Similarly, several 
studies have suggested an association between random genetic markers 
and T2D; however, for many of them, there is a lack of replication in sub-
sequent analyses (Rosenbloom et al. 1999, O’Rahilly et al. 2005, Willer et 
al. 2007). Currently, the most signifi cant susceptibility genes of T2D seem 
to be 1) the ABCC8 and KCNJ11 genes encoding sulfonylurea receptor 1 
(SUR1) and inwardly rectifying K+ channel (Kir6.2) subunits of the β-cell 
ATP-sensitive K+ channel, which plays a central role in glucose-stimulated 
insulin secretion (Inoue et al. 1996, Hani et al. 1998; summarized by van 
Dam et al. 2005); 2) the PPARG gene encoding a transcription factor that 
is involved in adipocyte diff erentiation and regulation of glucose and li-
pid homeostasis (Altshuler et al. 2000); and 3) the CAPN10 gene encoding 
cysteine protease calpain-10, which aff ects a variety of cellular functions 
and may play a role in insulin secretion, insulin action and HGP (Horikawa 
et al. 2000). Of these, the strongest evidence for replication has been docu-
mented for the Pro12Ala polymorphism in the PPARG, and for the Glu-
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23Lys polymorphism in KCNJ11 (Gloyn et al. 2003, Lohmueller et al. 2003, 
van Dam et al. 2005, Willer et al. 2007). Very recently, however, a strong 
association between variants in the TCF7L2 gene, encoding a transcription 
factor, and T2D was reported by Grant et al. (2006); with replication of the 
fi nding in several populations (Cauchi et al. 2006a, b, Damcott et al. 2006, 
Groves et al. 2006, Munoz et al. 2006, Saxena et al. 2006, Scott et al. 2006, 
Zhang et al. 2006). Th e mechanisms by which the variants in TCF7L2 aff ect 
glucose metabolism are at the moment unclear, but suggested mechanisms 
include eff ects on insulin secretion via the regulation of glucagon-like pep-
tide-1, and the regulation of genes involved in adipogenesis and/or adi-
pocyte function (Damcott et al. 2006, Grant et al. 2006).
Regarding the unravelling of possible nutrient-gene interactions in glu-
cose metabolism, of the prevailing susceptibility genes of T2D, PPARG is 
of special interest, as fatty acids have been shown to be the natural ligands 
of PPARs (Forman et al. 1997, Kliewer et al. 1997, Krey et al. 1997, Xu et al. 
1999), and as some results suggest an interaction between fatty acids and 
the Pro12Ala polymorphism of PPARG with respect to glucose metabo-
lism (Luan et al. 2001, Robitaille et al. 2003, Pisabarro et al. 2004).
2.3.1.1 Peroxisome proliferator-activated receptors as regulators of 
glucose metabolism
PPARs are nuclear receptors that function as ligand-activated transcrip-
tion factors. Th ey control the expression of numerous genes encoding for 
proteins involved in multiple pathways of energy, fatty acid and glucose 
metabolism, as well as in infl ammation and cell diff erentiation (Berger 
and Moller 2002, Wolf 2003, Fredenrich and Grimaldi 2004, Berger et al. 
2005).
Th e three PPAR subtypes, PPAR-α, PPAR-δ (also known as PPAR-β) 
and PPAR-γ, are encoded by three diff erent genes, and their tissue distri-
bution shows a distinct pattern (Jump and Clarke 1999, Evans et al. 2004). 
PPAR-α is predominantly present in liver, while PPAR-δ is expressed in 
numerous tissues, albeit most abundantly in muscle and white adipose tis-
sue (Wolf 2003, Evans et al. 2004). At least four isoforms of PPAR-γ (PPAR-
γ1, -γ2, -γ3 and -γ4) have been identifi ed (Sundvold and Lien 2001). Of 
these, PPAR-γ1 is expressed in many tissues (Ordovas and Corella 2004), 
while PPAR-γ2 is mainly expressed in adipose tissue, although detectable 
also at lower levels in, for instance, the pancreas (Lupi et al. 2004).
PPARs regulate the expression of target genes by dimerizing with an-
other nuclear receptor, retinoid X receptor (activated by 9-cis-retinoic 
acid), and by binding to a specifi c DNA sequence termed the peroxisome 
proliferator response element, which is located in the promoter region of 
target genes (Morrison and Farmer 2001, Shulman and Mangelsdorf 2005). 
PPARs exert their eff ects on gene expression through ligand-dependent 
binding of coactivator and corepressor proteins (Stanley et al. 2003, Shul-
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man and Mangelsdorf 2005). Th e binding of ligands to PPARs triggers a 
conformational change in the receptor, which results in the release of core-
pressors and an interaction with coactivators, leading to activation of the 
cellular transcriptional machinery (Berger et al. 1996, Stanley et al. 2003, 
Shulman and Mangelsdorf 2005).
PPARs have a large hydrophobic ligand-binding cavity, allowing them 
to bind a variety of ligands (Stanley et al. 2003). Th e receptors can be acti-
vated by saturated and unsaturated fatty acids, fatty acid derivatives, such 
as eicosanoids, and synthetic compounds (Forman et al. 1997, Kliewer et 
al. 1997, Krey et al. 1997, Xu et al. 1999, Evans et al. 2004, Shulman and 
Mangelsdorf 2005). PPAR-α, for example, is activated by lipid-lowering fi -
brate drugs (Kersten et al. 2000), and PPAR-γ by the antidiabetic thiazolid-
inediones (TZDs) (Berger et al. 2005). Importantly, plasma and tissue fatty 
acid levels in the human body are suffi  ciently high for PPAR activation 
(Jump and Clarke 1999, Morrison and Farmer 2001). Th erefore, the PPARs 
provide a molecular link between dietary fatty acids and gene expression 
(Morrison and Farmer 2001).
PPAR-α appears to promote fatty acid oxidation in liver, while PPAR-δ 
enhances fatty acid oxidation and energy uncoupling in skeletal muscle 
and adipose tissue (Wolf 2003). Th ese eff ects lead to lowered serum TG 
and NEFA levels, decreased lipid accumulation in muscle and liver and 
increased insulin sensitivity (Tanaka et al. 2003, Wolf 2003, Fredenrich and 
Grimaldi 2004, Berger et al. 2005, Grimaldi 2005).
PPAR-γ activation has been shown to promote adipogenesis, improve 
insulin sensitivity and reduce hyperglycaemia (Auwerx 1999). Th e tissue 
distribution of the receptor suggests that the eff ects are exerted primarily 
through adipose tissue, where it promotes preadipocyte diff erentiation 
into mature, TG-containing fat cells and promotes lipid storage in mature 
adipocytes (Rocchi and Auwerx 1999, Wolf 2003). As a result, lipid uptake 
and fatty acid storage in fat depots is enhanced, while lipolysis and NEFAs 
and TGs in the circulation, liver and muscle are diminished, thereby im-
proving insulin sensitivity (McGarry 2002, Berger et al. 2005). Th e activa-
tion of PPAR-γ leads also to enhancement of insulin-stimulated adipocyte 
glucose uptake via increased expression of GLUT4 and c-Cbl-associated 
protein, which is involved in the translocation of GLUT4 to the cell surface 
(Rangwala and Lazar 2004).
Th e activation of PPAR-γ modulates the endocrine activity of adipose 
tissue, resulting in changes in adipokine production that aff ect glucose 
metabolism in hepatic and peripheral tissues (Khan and Vanden Heuvel 
2003, Berger et al. 2005). For example, resistin, tumour necrosis factor-α 
and interleukin-6, which promote insulin resistance, are downregulated in 
response to PPAR-γ activation, while the expression of adiponectin, which 
potentiates insulin sensitivity, is upregulated (Havel 2002, Rangwala and 
Lazar 2004, Trayhurn and Wood 2004, Wolf 2004, Berger et al. 2005).
2.3 Aetiology of type 2 diabetes
22
Although PPAR-γ is expressed at extremely low levels in muscle, it seems 
to be important for the maintenance of whole-body insulin sensitivity, as 
muscle-specifi c PPAR-γ deletion was shown to cause insulin resistance in 
mice (Hevener et al. 2003, Norris et al. 2003). Furthermore, PPAR-γ, with 
predominance of the PPAR-γ2 isoform, is expressed in pancreatic islets, 
and its activation may play a role in preventing the untoward eff ects of 
increased NEFA levels on insulin secretion (Lupi et al. 2004).
To summarize, PPAR-γ has the potential to infl uence glucose metabo-
lism through a variety of mechanisms, highlighting the importance of fur-
ther studying its role in the pathogenesis of T2D.
Pro12Ala polymorphism of the PPAR-γ2 gene
Among the most consistent genetic predictors of T2D to date is the 
Pro12Ala polymorphism in the PPAR-γ2 gene (PPARG), which results in 
the substitution of an alanine for a proline due to a CCG-to-GCG missense 
mutation at codon 12 of exon 6 (Yen et al. 1997, Lohmueller et al. 2003, 
Hansen and Pedersen 2005). Although the fi rst results concerning the 
Pro12Ala variant with respect to the risk of T2D were discrepant, results 
of larger studies and a meta-analysis have shown that the Pro/Pro allele is 
associated with an ~ 1.25-fold increased risk for T2D (Altshuler et al. 2000, 
Lohmueller et al. 2003). As the diabetes-related high-risk allele is present 
in > 75% of individuals, this variant accounts for ~ 25% of the population-
attributable risk of T2D (Altshuler et al. 2000, McCarthy 2004, Hansen and 
Pedersen 2005).
In functional studies, the Pro12Ala substitution has reduced the binding 
affi  nity of the PPAR-γ2 protein to peroxisome proliferator response element 
in target genes and decreased its transcriptional activity (Deeb et al. 1998). 
Like heterozygous PPAR-γ defi ciency in mice (Miles et al. 2000), the re-
duced transcriptional activity in the Ala allele is associated with enhanced 
insulin sensitivity in humans (Deeb et al. 1998, Buzzetti et al. 2004). Th is 
may partly be due to reduced adipose tissue accumulation, as the Ala variant 
has been associated with lower BMI, although opposite observations have 
also been reported (Deeb et al. 1998, Berg 1999). In addition, the Ala allele 
has been associated with reduced NEFA delivery (Stumvoll et al. 2001) and 
increased insulin clearance (Tschritter et al. 2003), which probably contrib-
ute to the decreased T2D risk associated with the allele. Th e physiological 
consequences of the Pro12Ala polymorphism seem to be complex (Ordovas 
and Corella 2004); they may, for example, be diff erent in lean and obese 
subjects (Rocchi and Auwerx 1999). Furthermore, the Ala variant may pre-
dispose to long-term weight gain (Lindi et al. 2001), and be a risk factor for 
insulin defi ciency in subjects with T2D (Mori et al. 2001), although T2D 
subjects with this variant may also be more responsive to rosiglitazone treat-
ment (Kang et al. 2005). Interestingly, both activation and partial loss of 
PPAR-γ may increase insulin sensitivity (Yamauchi et al. 2001).
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As T2D is a multifactorial disease arising from interactions between 
genetic polymorphisms and environmental factors, it is of the utmost im-
portance to unravel how glucose metabolism is aff ected by the interaction 
of common variants, including the PPARG Pro12Ala polymorphism, with 
environmental factors (McCarthy 2004). Some results suggest an interac-
tion between the Pro12Ala polymorphism and physical activity on glucose 
metabolism (Adamo et al. 2005, Weiss et al. 2005). Th e few studies con-
ducted thus far on an interaction between the Pro12Ala polymorphism 
and dietary fatty acids with respect to glucose metabolism are discussed 
later (see Section 2.3.3.1.).
2.3.2 Obesity and physical inactivity
Obesity and a low level of physical activity typical for sedentary urban en-
vironments represent the most important modifi able risk factors for T2D 
(Parillo and Riccardi 2004, Steyn et al. 2004). Longitudinal studies have 
shown that weight gain is a powerful predictor of the disease (Helmrich et 
al. 1991, Colditz et al. 1995, Hu et al. 2001a). Both overall and abdominal 
adiposity independently increase the risk (Parillo and Riccardi 2004, Wang 
et al. 2005). And, conversely, weight loss and increased physical activity are 
eff ective ways to prevent or delay the development of T2D (Helmrich et al. 
1991, Colditz et al. 1995, Pan et al. 1997b, Tuomilehto et al. 2001, Knowler 
et al. 2002, Parillo and Riccardi 2004, Laaksonen et al. 2005).
2.3.3 Dietary factors
For decades, diet has been assumed to play an important role in the defects 
of glucose metabolism leading to T2D, as major alterations have been tak-
ing place in diets concomitantly with increasing T2D rates (Himsworth 
1935, Bennett et al. 1984, Simopoulos 2003). Th e nutritional requirements 
of man have been proposed to be shaped according to the foods available 
to pre-agricultural humans (lean meat, fi sh, green leafy vegetables, fruits, 
nuts, berries and honey), and therefore, the nutritional patterns in con-
temporary affl  uent nations are poorly compatible with the ancient genome 
(Simopoulos 2003, Cordain et al. 2005). Among nutritional characteris-
tics that have altered considerably over time are changes in the intake of 
the amount and type of fat, antioxidative nutrients (e.g., carotenoids and 
vitamin E) and dietary fi bre (Arab 2003, Simopoulos 2003, Cordain et al. 
2005). Modern societies are characterized by sedentary lifestyles, leading 
to an imbalance between energy intake and energy expenditure, and con-
temporary diets are low in n–3 fatty acids, natural antioxidants and fi bre 
(Simopoulos 2003). Affl  uent diets might also be poorly compatible with the 
thrift y metabolism programmed by a thrift y intrauterine environment.
Th e following text will provide a brief summary of the current knowl-
edge of the associations between glucose metabolism and dietary fatty 
acids, tocopherols, carotenoids and fi bre. Regarding fatty acids and anti-
2.3 Aetiology of type 2 diabetes
24
oxidative nutrients, the associations between their plasma/tissue levels as 
surrogates of dietary intake and glucose metabolism are also discussed. 
Th e emphasis is primarily on results of epidemiological studies and inter-
vention trials, but fi ndings from in vivo and in vitro experimental studies 
are also presented when discussing potential mechanisms by which these 
nutrients infl uence glucose metabolism.
2.3.3.1 Fatty acids
Dietary fatty acids are classifi ed as saturated (SFA), monounsaturated 
(MUFA) or polyunsaturated (PUFA) on the basis of the number of dou-
ble bonds in their hydrocarbon chain. Th e metabolism of fatty acids in 
the body is catalysed by elongases, which add carbon atoms to the car-
bon chain, and by desaturases, which introduce double bonds (Nakamura 
and Nara 2004). Delta-9 desaturase (also called stearoyl-CoA desaturase, 
SCD) catalyses the conversion of SFA precursors to MUFAs, while Δ6- and 
Δ5-desaturases catalyse the synthesis of very-long-chain unsaturated fatty 
acids. Th e activity of desaturases is mainly regulated by dietary PUFAs (all 
three desaturases are downregulated by high PUFA intake) (Nakamura 
and Nara 2004), but also by several hormones (Guéraud and Paris 1997). 
Many of the eff ects of fatty acids are dependent on their chain length and 
the number and position of double bonds (Stubbs and Smith 1990).
PUFAs occur in two functionally distinct families, the n–6 PUFAs 
and the n–3 PUFAs (a fatty acid with the fi rst double bond aft er the third 
carbon from the methyl end is termed n–3). As n–6 and n–3 fatty acids 
compete for the same enzymes (Holman 1986, Cook and Spence 1987), 
a high intake of one can inhibit elongation and desaturation of the other. 
Although the liver has been regarded as the main site for long-chain PUFA 
production, desaturases are also expressed in other tissues, including the 
brain, liver, lung, heart, skeletal muscle and pancreas (β-cells) (Cho et al. 
1999a, b, Ramanadham et al. 2002). Furthermore, human Δ5-desaturase is 
highly expressed in the foetal liver (Cho et al. 1999b, Leonard et al. 2000).
Putative mechanisms by which amount and composition of fat affect 
glucose metabolism
Fatty acids have several functions in the human body by which they may 
aff ect glucose metabolism. Fatty acids provide an effi  cient energy supply, 
but excessive fat accumulation is associated with increased NEFA levels, 
which may contribute to fat accumulation in non-adipose tissues (Kra-
gen et al. 1991), and thereby, to decreased glucose uptake and oxidation in 
muscle (Storlien et al. 1991, 1996a). Among the diff erent fatty acids, SFAs 
and n–6 PUFAs have been linked to accumulation of muscle triglycerides, 
while PUFAs of the n–3 series seem to direct fatty acids towards fatty acid 
oxidation (Storlien et al. 1991, Cortright et al. 1997, Clarke 2000, Lom-
bardo and Chicco 2006). N–3 fatty acids have been associated with lower 
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overall and central adiposity (Hill et al. 1993, Takahashi and Ide 2000, Jang 
et al. 2003, Lombardo and Chicco 2006). Excessive adiposity may induce 
insulin resistance also by altered delivery of fat-derived adipokines (Tray-
hurn and Wood 2004).
Th e proportion of fat in the diet has been directly related to insulin 
resistance and the deterioration of glucose tolerance, especially in experi-
mental animals (Kragen et al. 1991, Storlien et al. 1996a), but also in man, 
albeit more inconsistently (Storlien et al. 1996a, Parillo and Riccardi 2004). 
Th ere are some indications that in man only a long-term exposure to a 
high-fat diet induces insulin resistance (Storlien et al. 1996a). Th e unto-
ward eff ects of high fat intake on glucose metabolism seem to be partly 
mediated by obesity (Parillo and Riccardi 2004), but other mechanisms, 
investigated mainly in animal studies, are also evident. A high-fat diet may 
increase insulin release and lead to hyperinsulinaemia, with an ensuing 
decrease in the number of insulin receptors (Clarke 2000 and references 
therein). A high intake of fat is also associated with decreased insulin bind-
ing to its receptors and impaired insulin signalling (reviewed by Storlien et 
al. 1996a, Clarke 2000). Studies in rats have furthermore shown that high-
fat diets downregulate GLUT4 expression and activity, although the de-
creases can be attenuated with high-fat diets rich in n–3 PUFAs (Rosholt et 
al. 1994, Takahashi and Ide 2000). Finally, high-fat diets have been shown 
to be associated with reduced glycogen synthase in mouse skeletal muscle 
(Storlien et al. 1996a) and downregulation of the genes involved in oxida-
tive capacity in human and mouse skeletal muscle (Sparks et al. 2005).
Th e fatty acid composition of plasma and organelle membranes plays 
an important role in membrane function (Storlien et al. 1996a, b, Wiseman 
1996, Vessby et al. 2002). SFAs with single bonds introduce rigidity to cell 
membranes, thereby impairing various membrane functions such as insulin 
receptor binding and the translocation and activity of glucose transporters 
(Storlien et al. 1996a). Double bonds of unsaturated fatty acids contribute 
to the fl uidity of membranes with benefi cial eff ects on glucose metabolism 
(Stolien et al. 1996b), but are also more chemically reactive than single 
bonds, thus being able to produce a variety of oxidized products that con-
tribute to oxidative stress and membrane damage (see Section 2.3.3.2.). 
Fatty acids and their metabolites are furthermore used as modulators of 
cell signalling (Sampath and Ntambi 2005), and oxidative derivatives of 
fatty acids called eicosanoids are involved in, for example, infl ammation 
(Funk 2001) and vasodilatation of blood vessels (Arab 2003).
Fatty acids infl uence insulin secretion. Th e eff ects seem to be depend-
ent on chain length and the degree of unsaturation, may be dependent on 
whether studied in vitro or in vivo and may diff er acutely and in long term 
(Opara et al. 1994, Stein et al. 1997, McGarry and Dobbins 1999, Beysen et 
al. 2002). Th e insulinotropic eff ect of fatty acids in vitro appears to increase 
as a function of chain length (Stein et al. 1997), although the results are 
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not all congruent (Opara et al. 1994). Regarding the degree of saturation, 
fi ndings of in vitro studies are contradictory, showing increased secretion 
both with the degree of saturation (Stein et al. 1997) and with an increas-
ing number of double bonds (Opara et al. 1994). In rats, fi sh oil feeding 
normalized the impaired insulin secretion caused by a sucrose-rich diet 
(Pighin et al. 2003). In vivo in humans, the insulin response to glucose aft er 
an acute elevation of plasma NEFAs was highest for MUFAs and lowest for 
SFAs (Beysen et al. 2002). Over time, however, a high ratio of saturated to 
polyunsaturated NEFAs in the blood may induce hypersecretion of insu-
lin (McGarry and Dobbins 1999). Finally, SFAs, possibly in concomitance 
with elevated glucose concentrations, have been shown to impair β-cell se-
cretory function through reduction of proliferative capacity and induction 
of β-cell death; unsaturated fatty acids, on the other hand, are protective 
and may prevent the deleterious eff ects of SFAs (Eitel et al. 2002, El-Assaad 
et al. 2003, Maedler et al. 2003). 
Dietary and plasma fatty acid composition is associated with low-grade 
infl ammation, which has recently been observed to be related to insulin 
resistance and T2D (Pannacciulli et al. 2001, Pradhan et al. 2001, Hu and 
Stampfer 2003, Weigert et al. 2004). High levels of SFAs have been associ-
ated with increased levels and PUFAs from the n–3 series with decreased 
levels of C-reactive protein and interleukin-6 (Fernández-Real et al. 2003, 
Rallidis et al. 2003, Simopoulos 2003, Bemelmans et al. 2004, Weigert et 
al. 2004, Ajuwon and Spurlock 2005, Klein-Platat et al. 2005). Results con-
cerning n–6 fatty acids have been less consistent; both anti- and proin-
fl ammatory associations have been reported (Fernández-Real et al. 2003, 
Simopoulos 2003, Weigert et al. 2004, Klein-Platat et al. 2005, Sampath and 
Ntambi 2005).
Finally, fatty acids have the potential to aff ect glucose metabolism by 
regulation of gene expression via, for instance, membrane composition, 
intracellular calcium levels and eicosanoid production (Jump and Clarke 
1999, Khan and Vanden Heuvel 2003, Sampath and Ntambi 2005). Im-
portantly, fatty acids and their metabolites have been observed to regulate 
gene expression also directly via nuclear receptors, such as liver X recep-
tors, hepatocyte nuclear factor-4α and PPARs, all of which are involved 
in glucose metabolism (Jump and Clarke 1999, Khan and Vanden Heuvel 
2003, Sampath and Ntambi 2005).
Prevailing notion about relationships between fatty acids and glucose 
metabolism
Associations of dietary fat amount and composition with glucose metabo-
lism in man have been investigated during recent decades in numerous 
studies with diff erent study designs. Findings from observational epide-
miological studies and controlled intervention trials were summarized in 
a recent report of joint WHO/FAO expert consultation on diet, nutrition 
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and prevention of chronic diseases (World Health Organization 2003, see 
also Steyn et al. 2004). As regards dietary fat, the strength of evidence avail-
able thus far was seen as probable for SFAs to increase the risk of T2D, as 
possible for high total fat intake and trans fatty acids to increase the risk 
and as possible for n–3 PUFAs to reduce the risk. According to a review by 
Parillo and Riccardi (2004), based primarily on epidemiological studies, a 
high intake of unsaturated fatty acids may potentially be associated with a 
decreased risk of T2D, and those of saturated and trans fatty acids with an 
increased risk.
Th e fatty acid composition in serum lipids and skeletal muscle mem-
branes typical of insulin-resistant and diabetic states has usually been high 
in palmitic and palmitoleic acid, but low in unsaturated fatty acids (Vessby 
et al. 2002, Vessby 2003). Th ese associations have been interpreted to be 
mainly explained by the fatty acid composition of the diet, although other 
factors may also play a role.
Some of the discrepancy in the results concerning associations between 
dietary fat and glucose metabolism is probably due to such methodological 
issues as population diff erences, sample size, limitations of methods used 
and diff erent control for potential confounding factors. However, T2D is 
a multifactorial disease in which the phenotype of a subject is defi ned by 
interaction of genetic polymorphisms with environmental factors. Th ere-
fore, the failure to take into account the genetic variation among study 
subjects may be one factor underlying the inconsistent results (Bessesen 
2001). Limited data thus far have suggested an interaction between dietary 
fat composition and polymorphisms linked to elevated TG concentrations 
(SstI polymorphism in the apolipoprotein C-III gene) (Salas et al. 1998), 
insulin resistance (Ala54Th r polymorphism in the intestinal fatty acid 
binding protein FABP2) (Marín et al. 2005) and coronary heart disease 
(–219G/T polymorphism in the apolipoproteinE gene promoter) (Moreno 
et al. 2005) with respect to associations with glucose metabolism.
Fatty acids probably exert some of their regulatory functions on me-
tabolism through PPARs, for which they are natural ligands (Kliewer et 
al. 1997, Auverx 1999, Xu et al. 1999). Th e limited data available thus far 
suggest that the PPARG Pro12Ala genotype may be an important modi-
fi er of human physiological responses to dietary fat. Nieters et al. (2002) 
found an interaction between dietary arachidonic acid and the Pro12Ala 
polymorphism on the risk for obesity; only carriers of the Ala allele were at 
greater risk with increasing arachidonic acid intake. In the Nurses’ Health 
Study population, the Pro12Ala polymorphism modifi ed associations of 
total and monounsaturated fat with BMI (Memisoglu et al. 2003); a direct 
trend was observed between the intake of total fat and BMI in Pro/Pro ho-
mozygotes, but not in Ala allele carriers, while the intake of monounsatu-
rated fat was inversely associated with BMI in Ala allele carriers, but not 
in Pro/Pro homozygotes. Furthermore, in carriers of the Ala allele, the de-
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cline in serum TGs in response to fi sh oil supplementation may be greater 
(Lindi et al. 2003).
Results about interactions between dietary fatty acids and the PPARG 
Pro12Ala polymorphism on glucose metabolism are limited. In the study 
of Luan and co-workers (2001), the ratio of dietary PUFAs to SFAs was 
inversely related to the fasting insulin concentration in Ala allele carriers, 
but not in Pro/Pro homozygotes. In a later report by these investigators, 
the inverse association between the ratio of dietary PUFAs to SFAs and 
the fasting insulin concentration was only found in physically active Ala 
allele carriers (Franks et al. 2004). Pisabarro et al. (2004) describe a high 
intake of trans fatty acids, as well as of SFAs, to be associated with glucose 
intolerance only in the Ala allele carriers. Robitaille et al. (2003), by con-
trast, report a direct correlation of saturated fat intake with fasting glucose 
in Pro/Pro homozygotes, but not in Ala allele carriers. Reasons for these 
discrepancies are at present obscure, and the topic clearly warrants further 
attention.
2.3.3.2 Tocopherols and carotenoids
Tocopherols
Vitamin E is a fat-soluble vitamin that occurs in nature in eight structurally 
related forms: α-, β-, γ- and δ-tocopherol, and α-, β-, γ- and δ-tocotrienol 
(Brigelius-Flohé et al. 2002). In the circulation, vitamin E is transported in 
plasma lipoproteins, and its plasma concentrations are controlled by the 
liver in association with the control of lipoprotein metabolism (Traber and 
Arai 1999).
A high intake of vitamin E has been suggested to be protective against 
many chronic diseases, including T2D (Brigelius-Flohé et al. 2002). As vi-
tamin E is a lipophilic antioxidant, which protects membranes from lipid 
peroxidation, the putative benefi cial eff ects have been mainly ascribed to 
the antioxidative properties (Caballero 1993). Oxidative stress refers to the 
imbalance between the generation of highly reactive nitrogen and oxygen 
species and their removal through the antioxidant defence systems. It leads 
to tissue damage (Wiseman 1996) and has been linked to the impairment 
of insulin action and β-cell function, as well as to the development of T2D 
(Paolisso and Giugliano 1996, Facchini et al. 2000, Evans et al. 2002, Urakawa 
et al. 2003, Ceriello and Motz 2004). Th e eff ects would be mediated, e.g., 
through decreased membrane fl uidity, resulting in altered activity of the in-
sulin receptor and interference with glucose uptake, or through common 
stress-activated signalling pathways such as nuclear factor-κB (Caballero 
1993, Wiseman 1996, Evans et al. 2002). Th e trigger of oxidative stress has 
been speculated to be elevated NEFA or glucose levels, or both (Evans et al. 
2002, Lewis et al. 2002, Ceriello and Motz 2004, Poitout et al. 2006).
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Besides antioxidant eff ects, tocopherols have been shown to regulate cell 
signalling and gene expression, to aff ect infl ammation and to play a role in 
the preservation of endothelial function (Azzi et al. 2000, Jiang et al. 2000, 
Laight et al. 2000, Brigelius-Flohé et al. 2002, Jiang and Ames 2003, Wag-
ner et al. 2004, Wu et al. 2005). Some of the benefi cial eff ects of vitamin E 
on glucose metabolism may thus occur via the inhibition of protein kinase 
C, possibly through nuclear factor-κB inhibition (Traber and Packer 1995, 
Azzi et al. 2000, Brigelius-Flohé et al. 2002, Evans et al. 2002). γ-Tocophe-
rol could infl uence glucose metabolism through anti-infl ammatory eff ects 
(Jiang et al. 2000, Jiang and Ames 2003, Wagner et al. 2004). Vitamin E 
may furthermore play a role in the preservation of insulin action through 
the maintenance of endothelial function (Laight et al. 2000). Endothelial 
dysfunction has recently been linked to abnormal glucose homeostasis 
(Vehkavaara et al. 1999, Hu and Stampfer 2003).
Benefi cial eff ects on glucose metabolism have been supported by some 
(Paolisso et al. 1993, 1994, 1995), but not all (Meydani et al. 1994, 1998, 
Miller et al. 1997) human studies that have investigated the eff ects of phar-
macological vitamin E doses (e.g., 800 mg/d). Evidence from epidemiolog-
ical studies is also inconsistent. In one study, vitamin E intake was directly 
related to insulin sensitivity in vitamin E supplement users (Facchini et al. 
1996), while in another the intake of vitamin E from food and supplements 
was unrelated to insulin sensitivity aft er adjustment for energy intake and 
BMI (Sanchez-Lugo et al. 1997). Th e intake of vitamin E has been both 
inversely related (Boeing et al. 2000, Bates et al. 2004) and unrelated (Shoff  
et al. 1993) to glycated haemoglobin (GHb), and one cohort study found 
dietary intakes of α-, γ- and δ-tocopherol as well as that of β-tocotrienol to 
be inversely related to the risk of T2D (Montonen et al. 2004).
Th e concentrations of plasma vitamin E, α-tocopherol and δ-tocopherol 
have been inversely associated with insulin resistance and insulin levels in 
several studies (Öhrvall et al. 1993, Decsi et al. 1996, Facchini et al. 2000), 
as well as with glucose concentration in one study (Ford et al. 2005). In the 
latter study, γ-tocopherol concentration, by contrast, was directly related 
to glucose concentration and GHb. A similar direct association between 
plasma γ-tocopherol and GHb was observed by Bates et al. (2004). In one 
cohort study, low plasma vitamin E concentration was associated with in-
creased risk of T2D (Salonen et al. 1995), but in another longitudinal study, 
the inverse association between serum α-tocopherol and the risk of T2D 
was abolished aft er adjustment for cardiovascular risk factors (Reunanen 
et al. 1998). Mayer-Davis et al. (2002) found in their follow-up study that 
in vitamin E supplement non-users the dietary intake of vitamin E was un-
related to T2D incidence, while a high plasma α-tocopherol level showed 
a protective association. In vitamin E supplement users, by contrast, no 
protective eff ect was observed for either reported intake of vitamin E or the 
plasma concentration of α-tocopherol. 
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Based on the data available until the year 2003, the conclusion of the 
joint WHO/FAO expert consultation on diet, nutrition and prevention of 
chronic diseases was that vitamin E could decrease the risk of T2D, but the 
evidence was insuffi  cient (World Health Organization 2003). Th ereaft er, 
however, results of two intervention studies have been reported. According 
to Czernichov et al. (2006), neither baseline dietary or plasma vitamin E 
nor supplementation with antioxidant vitamins and minerals, including 30 
mg of vitamin E for 7.5 years, had any eff ect on fasting plasma glucose con-
centration. In the Women’s Health Study, 600 IU of vitamin E every other 
day for 10 years also had no impact on the risk of T2D (Liu et al. 2006).
Carotenoids
Carotenoids are a family of natural pigments with hundreds of members. 
Of the major dietary carotenoids present in vegetables and fruits, α- and 
β-carotene exhibit, while lycopene is devoid of provitamin A activity (Rock 
et al. 1996, Stahl and Sies 1996, 1997, Clinton 1998). Carotenoids are trans-
ported in the circulation by lipoproteins, and they concentrate in certain 
tissues, including the liver (Rock et al. 1996, Clinton 1998, Rao and Agar-
wal 1999).
Besides tocopherols, carotenoids are another group of antioxidant nu-
trients assumed to exert benefi cial eff ects on health, including on glucose 
metabolism (Rock et al. 1996, Clinton 1998). Whether the antioxidant 
property of carotenoids is primarily responsible for putative benefi cial ef-
fects has, however, been questioned (Pryor et al. 2000). Carotenoids also 
have other biological functions, including the ability to modulate gene ex-
pression and to enhance gap junction communication between cells (Rock 
et al. 1996, Stahl and Sies 1996, Rao and Agarwal 1999, Pryor et al. 2000). 
Furthermore, the eff ects of carotenoids may be mediated not only by the 
carotenoid itself but also via retinoid metabolites or other derivatives. For 
example, retinoic acid may, by acting through retinoid X receptors, infl u-
ence cell diff erentiation and proliferation (Pryor et al. 2000).
Data on associations between dietary and plasma carotenoids and glu-
cose metabolism are inconsistent. While the intake of β-carotene has been 
unrelated to GHb in cross-sectional studies (Shoff  et al. 1993, Boeing et al. 
2000), high dietary intake of β-cryptoxanthin was linked to a decreased 
risk of T2D in one cohort study (Montonen et al. 2004). A recent study by 
Wang et al. (2006), found no relationship between the intake of lycopene 
or the consumption of lycopene-rich tomato-based food products and the 
risk of T2D in women.
Th e serum concentrations of carotenoids (including α- and β-carotene, 
lycopene and/or lutein) were inversely related to fasting serum insulin 
concentration or insulin resistance in the cross-sectional studies of Ford et 
al. (1999), Facchini et al. (2000) and Coyne et al. (2005). Some of the caro-
tenoids also showed inverse associations with fasting and/or 2-h glucose 
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levels and with the degree of glucose intolerance (Ford et al. 1999, Coyne 
et al. 2005). In a cross-sectional study among subjects without a diagnosis 
of diabetes, plasma lycopene concentration showed an inverse association 
with GHb (P = 0.06) (Bates et al. 2004). Serum β-carotene was not as-
sociated with the risk of T2D independent of cardiovascular risk factors 
(Reunanen et al. 1998), and also supplementation with β-carotene (50 mg 
on alternate days) for 12 years was unrelated to T2D risk in men (Liu et al. 
1999). Moreover, in the study by Czernichov et al. (2006), supplementation 
with antioxidant vitamins and minerals including 6 mg of β-carotene for 
7.5 years had no eff ect on fasting plasma glucose, although the baseline 
dietary and plasma concentrations of β-carotene were inversely associated 
with the outcome variable.
To summarize, results concerning associations of tocopherols and caro-
tenoids with glucose metabolism are inconsistent. Reasons for discrepan-
cies are unclear, although characteristics of the study populations, such as 
genetic heterogeneity, could have played a role. Th erefore, associations be-
tween antioxidative nutrients and glucose metabolism should be studied in 
subjects at high risk for T2D. In these subjects, antioxidant intake may play 
a special role due to the underlying abnormalities in glucose metabolism 
precipitating oxidative stress and predisposing to T2D.
2.3.3.3 Dietary fi bre
Dietary fi bre refers to edible parts of dietary components that are resistant 
to digestion and absorption in the human small intestine, but neverthe-
less exert diverse physiological eff ects with demonstrable health infl uences 
(Ha et al. 2000, American Association of Cereal Chemists 2001). Agree-
ment about the exact defi nition of dietary fi bre has not been reached (Food 
and Agriculture Organization 1998), but according to the defi nition by the 
American Association of Cereal Chemists (2001), it includes polysaccha-
rides, oligosaccharides, lignin and associated plant substances.
A traditional way to classify dietary fi bre has been as soluble and insolu-
ble. Vegetables, legumes, fruits and berries are a good source of soluble fi -
bre, which reduces the rate of glucose absorption in the small intestine and 
thus attenuates postprandial blood glucose response (Jenkins et al. 2000), 
possibly via increased skeletal muscle plasma membrane GLUT4 content 
(Song et al. 2000). Whole-grain products are rich in insoluble fi bre, which 
is non-viscous and has no eff ect on glucose absorption, but nevertheless has 
been associated with increased insulin sensitivity; though possible mecha-
nisms have remained obscure (Jenkins et al. 2000). Further mechanisms 
by which dietary fi bre could aff ect glucose metabolism include decreased 
infl ammation (Ma et al. 2006) as well as increased intestinal proglucagon 
gene expression and secretion of proglucagon-derived peptides, such as 
glucagon-like peptide-1, with ensuing reduction in gastric emptying rates, 
enhancement of glucose uptake and disposal in peripheral tissues, reduced 
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HGP and eff ects on insulin secretion (Reimer et al. 1997, Massimino et al. 
1998, American Dietetic Association 2002, Holst and Gromada 2004). Fur-
thermore, high-fi bre diets lead to increased production of short-chain fatty 
acids by intestinal bacteria, which might through increased hepatic glu-
cose oxidation, increased hepatic insulin clearance and decreased NEFA 
release improve insulin sensitivity (McKeown and Mayer 2004). Finally, 
fi bre can be a marker for other components of fi bre-rich foods, e.g., mag-
nesium and thiamine, which may be partially responsible for the benefi cial 
eff ects (Bakker et al. 1998, Venn and Mann 2004).
Since the proposal of Trowell (1975) about a role of dietary fi bre in the 
aetiology of diabetes, several epidemiological and experimental studies 
have explored the topic. Results available up to the time of gathering of 
the present dietary data were concluded to support a benefi cial role for 
soluble but not necessarily for insoluble fi bre in glucose metabolism (Fes-
kens 1992). Since then, several studies have, however, found an inverse 
association between the intake of insoluble cereal fi bre and future T2D 
(Salmerón et al. 1997a, b, Stevens et al. 2002, Montonen et al. 2003, Schulze 
et al. 2004; reviewed by Parillo and Riccardi 2004 and Montonen 2005). 
Th e overall inference has recently been that increased intake of (insoluble) 
dietary fi bre is associated with benefi cial eff ects on insulin sensitivity and 
protects against the development of T2D (Bessesen 2001, World Health 
Organization 2003, Parillo and Riccardi 2004, Steyn et al. 2004, Venn and 
Mann 2004, Lindström 2006). Th e topic has not, however, been studied in 
relatives of patients with T2D.
Summary
To conclude, the prevailing literature on associations between glucose me-
tabolism and fatty acids, tocopherols, carotenoids (and dietary fi bre) is in-
consistent. One underlying factor behind the discrepant results may be the 
genetic heterogeneity of the study populations. Although the presence of 
a genetic component contributing to the individual metabolic response to 
dietary intake has been assumed for quite a while (Holtzman 1988), it was 
not until recent years that nutrient-gene interaction studies (referred to as 
’nutritional genetics’ or ’nutrigenetics’ studies) have begun to reveal data 
on the diff erent responsiveness among individuals to the same diet due to 
genetic variations (Gillies 2003, German 2005). Investigating the associa-
tions in high-risk populations and exploring possible nutrient-gene inter-
actions are, however, essential for improving the understanding of T2D 
aetiology (Saltiel and Kahn 2001). Ideally, this information would help to 
develop prevention programmes that take into account the genetic predis-
position to the disease.
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3 Aims of the Study
Th is study was undertaken to investigate in non-diabetic relatives of pa-
tients with T2D cross-sectional associations of the following dietary fac-
tors with insulin resistance, β-cell function and/or basal and post-load glu-
cose and NEFA levels:
1. Total fat intake and dietary and plasma cholesterol ester fatty acids (I 
and II). Possible interactions of fatty acids with the PPARG Pro12Ala 
polymorphism on the outcome variables were taken into considera-
tion.
2. Dietary and plasma carotenoids (α- and β-carotene and lycopene) and 
α- and γ-tocopherol (III).
3. Total, water-insoluble and water-soluble dietary fi bre (IV).
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4 Subjects and Methods
4.1 Subjects and study design
Th e Botnia Dietary Study investigates relationships of dietary factors to 
measures of glucose metabolism in relatives of patients with T2D, com-
prising a high-risk group for the disease. Th e gathering of the dietary data 
occurred in conjunction with the follow-up investigation of the Botnia 
Study, which is a prospective family study on genetic and metabolic defects 
of T2D initiated along the western coast of Finland in 1990 (Groop et al. 
1996, Tripathy et al. 2000). At the beginning of the main Botnia Study, all 
patients with known T2D from four health care centres (Jakobstad, Kor-
sholm, Malax-Korsnäs and Närpes), their family members and spouses 
without a family history of diabetes were invited to participate. Th e study 
includes the baseline investigation and follow-up examinations. Th e Bot-
nia Study protocol was approved by the local ethics committees.
Th e Botnia Dietary Study was initiated in October 1994. Th e inclusion 
criteria of the dietary study were as follows: 1) a fi rst-degree (including 
parents, children and siblings) or second-degree (including grandparents, 
grandchildren, aunts, uncles and children of siblings) family history of 
T2D, 2) an age of 20-70 years at the time of the Botnia baseline investi-
gation and 3) normal glucose tolerance (NGT) or IGT according to the 
1985 WHO criteria (World Health Organization 1985). Family history of 
T2D was determined from hospital records or by an OGTT (Groop et al. 
1996).
Th e formation of the study population is depicted in Figure 2. By June 
1997, a consecutive sample of 746 subjects who fulfi lled the inclusion cri-
teria had been invited to participate. Of those invited, 603 (81%) agreed 
to participate and completed the fi rst 3-day food record acceptably (two 
subjects were excluded because of incomplete recording done aft er the as-
signed study days). Two 3-day food records were completed by 590 subjects 
(79%). Fourteen subjects with newly diagnosed diabetes according to the 
latest WHO criteria (Alberti and Zimmet 1998) at the time of the dietary 
study were excluded from the analyses. Exclusions because of missing data 
and other criteria are detailed in the original publications.
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4.2 Measurement of dietary intake
Dietary intake was measured by means of two 3-day estimated food records 
on average 6 months (range 5-11) apart. In Studies I, II and III, average 
food consumption and nutrient intakes were determined from the fi rst 3-
day period only, as in these studies data on plasma levels of nutrients were 
used as well, and plasma data were available only from the time of the fi rst 
recording period. In Study IV, dietary intake data from both 3-day food 
records were combined.
4.2 Measurement of dietary intake
746 non-diabetic relatives of patients with T2D
invited from four health care centres 
Subsample of 308 subjects unrelated  
to each other selected at random  
from two health care centres 
71 subjects refused 
to participate 
237 unrelated subjects participated and 
completed the 3-day food record 
143 subjects
refused to
participate 
Study III 
(n = 182) 
Study I 
(n = 567) 
603 subjects participated and completed the first 
3-day food record 
Study II 
(n = 571) 
Study IV 
(n = 552) 
590 subjects completed two 3-day  
food records 
13 subjects 
refused to 
complete the 
second
3-day food 
record
Figure 2. Formation of the study populations. Exclusions because of missing data and 
other criteria are detailed in the original publications
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Th e protocol of the Botnia Dietary Study included altogether three vis-
its to the local health care centre. During the fi rst visit, the purpose of the 
dietary study was explained to subjects fulfi lling the inclusion criteria and 
their willingness to participate was ascertained. Th is visit included a medi-
cal examination, including a standard OGTT and a structured interview on 
demographic data performed by trained research staff . During the second 
visit, which occurred as soon as possible aft er the recording period, the 
food record was checked, and in two of the health care centres an IVGTT 
was performed. For the second recording period aft er about 6 months, the 
food record form was sent to participants, and aft er the recording, partici-
pants visited the health care centre once more to return the form.
Th e fi eld work of the dietary study was undertaken by local research staff  
aft er completing an intensive training programme during which they were 
taught how to keep a food record, how to instruct the participants about the 
recording and how to check the record. Th e collection of dietary data was 
overseen by the primary researcher (KY) throughout the study period. 
Th e subjects who agreed to participate in the dietary study were given 
a food record form and requested to complete it over a 3-day consecutive 
period, detailing all foods and drinks consumed. Recording days were as-
signed by the research staff , and each 3-day period included two weekdays 
and one day of the weekend. Detailed verbal instructions on fi lling in a food 
record were given individually, but the recording form also included writ-
ten instructions. Participants were advised to record every item of food or 
drink consumed in as detailed a manner as possible immediately aft er each 
eating episode. Information on food preparation methods and brand names 
and details of individual ingredients of composite dishes were requested. It 
was emphasized that it was very important not to change customary food 
habits, i.e., the amount or type of the food or drink consumed during the 
study period. Th e amount of food and drink was estimated using a booklet 
of food photographs with diff erent portion sizes (Haapa et al. 1985) or with 
household measurement units. Th e fi gures of the portion size booklets were 
supplied with legends in Swedish, as most of the study subjects were Swed-
ish-speaking. Th e intake of dietary supplements was also recorded.
Aft er the recording period, the participants visited the health care cen-
tre and returned the completed food record, which was then reviewed 
by the research staff  for recording defi ciencies. Any ambiguities were re-
solved with the participant. Aft er receiving the food records, the primary 
researcher (KY) reviewed them once more, and if missing information was 
evident, the research staff  was asked to contact the participant by phone for 
completion of data.
Food intake data were entered into the computer by the researcher (KY) 
and by a student majoring in nutrition. Th e data were analysed using the 
soft ware and the Finnish National Food Composition Database developed 
and maintained at the National Public Health Institute, Helsinki, Finland 
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(Ovaskainen et al. 1996). Th e nutritional information of the database is 
based on Finnish food analyses and international food composition tables. 
To maximize the accuracy of the nutrient intake data, recipes and ingredi-
ents specifi ed in the food records were input for analysis. In addition, local 
bread, commonly consumed by study participants, was added to the nutri-
ent database using the manufacturer’s information on the food label. Data 
on the content of dietary supplements were obtained from the National 
Food Administration and from manufacturers.
4.3 Medical examination
Th e participants visited the local health care centre in the morning aft er an 
overnight fast. During the medical screening, weight, height, waist and hip 
circumferences and blood pressure were measured, samples for the meas-
urements of serum lipids, plasma cholesterol ester fatty acids, carotenoids 
and tocopherols drawn, an OGTT performed, and data on demographic 
characteristics obtained.
During a standardized 75-g OGTT, blood samples for the measurement 
of plasma glucose and serum insulin were drawn at -5, 0, 30 and 120 min, 
and for serum NEFA at 0 and 120 min. During the second visit, aft er com-
pletion of the fi rst 3-day food record, subjects attending the health care 
centres in Malax-Korsnäs and Närpes underwent an IVGTT, in which a 
bolus of glucose (300 mg/kg body weight in a 50% [by vol] solution) was 
administered intravenously within 2 min. Samples for the measurement of 
serum insulin were drawn at -10, -5, 0, 2, 4, 6, 8 and 10 min.
For anthropometric measures, the subjects were standing and dressed 
in light indoor clothing without shoes. Body weight and height were meas-
ured, and BMI was used as the measure of relative body weight. Waist cir-
cumference was measured with a soft  tape midway between the lowest rib 
and the iliac crest, and hip circumference over the widest part of the gluteal 
region. Th e waist-to-hip ratio (WHR) was used as the measure of central 
adiposity. Blood pressure was measured aft er 30 min of rest from the right 
arm with the subject seated. Th e average of the two readings was used.
4.4 Structured questionnaire on demographic data and 
physical activity
Data on smoking, education and physical activity (Mälkiä et al. 1988) were 
obtained by a structured questionnaire. Th e level of education was defi ned 
as the total number of years of school and professional education.
Data on physical activity during the last 12 months were changed to 
metabolic equivalents (METs), which represent an estimate of the relative 
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intensity of activity and describe the amount of energy needed during ex-
ercise compared with resting energy expenditure (1 MET is approximately 
equal to an energy expenditure of 1 kcal [4.2 kJ]/kg of body weight per 
hour). Physical activity at work was reported according to a seven-point 
scale, ranging from no work and no activity (MET = 1.5) to very heavy 
manual work (MET = 10.0). Exercise while travelling to work was classi-
fi ed by tertiles: the fi rst tertile represented travel by motor vehicle (MET = 
1.5), the second by walking (MET = 3.5) and the third by bicycle (MET = 
5.0). Leisure time exercise received MET values from 2.0 to 12.5 depend-
ing on the type and intensity of the activity. Th e sum of MET values during 
work, the work trip and leisure time described the total physical activity 
and was used in statistical analyses.
4.5 Measurement of glucose metabolism
Th e main outcome variables used to describe glucose metabolism were in-
sulin resistance, β-cell function, and fasting and 2-h post-load (OGTT) 
plasma glucose concentrations. Fasting and 2-h serum NEFA levels during 
the OGTT were used as additional outcome variables.
Insulin resistance was determined by the homeostasis model assess-
ment - insulin resistance index (HOMA-IR), which estimates insulin sen-
sitivity from fasting plasma glucose and fasting serum insulin concentra-
tions (Matthews et al. 1985). Low HOMA-IR values indicate low insulin 
resistance (and high insulin sensitivity), whereas high HOMA-IR values 
indicate high insulin resistance (and low insulin sensitivity).
Beta-cell function was described by two variables. Th e insulinogenic 
index (IGI) was calculated as the ratio of the increment in serum insulin 
concentration at 30 min to the increment in plasma glucose concentration 
at 30 min during the OGTT ([Ins30-Ins0] / [Glu30-Glu0]) (subjects with a 
30-min glucose concentration less than or equal to the fasting glucose con-
centration were excluded from the analyses concerning this outcome vari-
able) (Phillips et al. 1994). To describe fi rst-phase insulin secretion during 
an IVGTT, the incremental area under the insulin curve during the fi rst 10 
min of the IVGTT was calculated. Low values of these variables are mark-
ers of fi rst-phase β-cell dysfunction.
Fasting and 2-h glucose concentration values during the OGTT were 
used as indicators of glucose tolerance. Glucose tolerance status (NGT, 
IFG, IGT or diabetes) at the time of the dietary study was determined ac-
cording to the latest WHO criteria (Alberti and Zimmet 1998).
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4.6 Assays
Glucose, insulin, NEFA and lipids. Plasma glucose concentrations were 
measured with a glucose oxidase method (Beckman Glucose Analyser II, 
Beckman Instruments, Fullerton, CA). Serum insulin concentrations were 
measured by radioimmunoassay (Pharmacia, Uppsala, Sweden), with an 
interassay coeffi  cient of variation < 9%. Serum NEFA concentrations were 
measured by an enzymatic colorimetric method using a commercially 
available kit (Wako Chemicals GmbH, Neuss, Germany). From fasting ve-
nous samples, serum TG and total and high-density lipoprotein (HDL) 
cholesterol concentrations were measured by enzymatic methods using the 
Cobas Mira autoanalyser (Hoff man-La Roche, Basel, Switzerland). Serum 
HDL cholesterol concentration was measured enzymatically aft er precipi-
tation of the apoB-containing lipoproteins with heparin and manganese 
chloride. Serum low-density lipoprotein (LDL) cholesterol concentration 
was calculated from fasting total cholesterol, TG and HDL cholesterol val-
ues using the Friedewald formula (Friedewald et al. 1972) if the serum TG 
concentration did not exceed 5 mmol/l.
Genotyping. Th e PPAR-γ2-exon 6 Pro12Ala polymorphism was geno-
typed by polymerase chain reaction - restriction fragment length polymor-
phism (PCR-RFLP) method and agarose gel electrophoresis using primers 
5’- GAT AGA GAC AAA ATA TCA GTG (forward) and 5’- GTA TCA 
GTG AAG GAA TCG CTT TCC G (reverse). PCR was carried out in a 
20-μl volume containing 5XNH4-buff er, 10 μmol/l of each dNTP, 3 mmol/l 
MgCl2, 0.5 U Taq polymerase (Amersham Pharmacia Biotech), 1.5% for-
mamide, 4 pmol of each primer and 25 ng of genomic DNA. Th e cycling 
conditions were 96ºC for 3 min, 38 cycles of 96ºC for 30 s, 56ºC for 30 s and 
72ºC for 60 s, followed by a fi nal extension at 72ºC for 10 min. PCR prod-
ucts were followed by digestion with BstU-1 at 60ºC for 2 h and separated 
on 6% agarose gel (SeaKem) stained with ethidium bromide. Th e common 
allele 1 (Pro12) gave a 113-bp fragment and the variant allele 2 (Ala12) 87-
bp and 25-bp fragments.
Plasma cholesterol ester fatty acid composition. For plasma cholesterol 
ester fatty acid determinations, a fasting sample was drawn and initially 
stored for 1-3 months at -20°C and thereaft er at -70°C until analysed. Se-
rum fat was extracted from plasma with dichoromethane-methanol (Folch 
et al. 1957), cholesterol esters separated by thin-layer chromatography 
(Merck silica gel G 0.25 mm) and methylated with acidic methanol (5% 
H2SO4) at 85°C for 2 h to produce methyl esters (Stoff el et al. 1959). Th e 
percentage composition of the sample was determined with an HRGC 412 
Micromat gas chromatograph (HNU Nordion Instruments, Helsinki, Fin-
land) equipped with a 25-m-long NB-351 column (I.D. 0.32 mm, phase 
layer 0.20 μm, HNU-Nordion Instruments), split injection, helium as car-
rier gas in a temperature program from 180°C to 230°C. Peaks from 14:0 
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to 22:6n–3 were identifi ed and the percentage composition calculated with 
a Sunicom Workstation (Helsinki, Finland). Th e composition of identifi ed 
fatty acids was normalized to 100%. Between-series variability was 1-3% 
for peaks over 4% and 5-10% for smaller peaks (for docosahexaenoic acid 
[DHA] 35%).
Plasma tocopherols and carotenoids. Plasma concentrations of α- and γ-
tocopherol, α- and β-carotene and lycopene were analysed from the same 
fasting samples as plasma cholesterol ester fatty acid composition. To 0.2 
ml of plasma, tocol and echinenon as internal standards for tocopherols 
and carotenoids, respectively, and a solution (50% [by vol] ethanol) con-
taining 1% (by vol) ascorbic acid were added. Aft er extraction with hexane, 
the tocopherols (Anttolainen et al. 1996) and carotenoids (Bieri et al. 1985) 
were analysed separately by high-performance liquid chromatography. Ra-
tios of peak height to internal standard were compared with those of ref-
erence plasma for which concentration values were traceable to certifi ed 
serum standards (standard reference material 968b; National Institute of 
Standards and Technology, Gaithersburg, MD). Th e precision between se-
ries was 5.7% for tocopherols and 7.9% for carotenoids.
4.7 Statistical analyses
Statistical analyses were performed with the statistical packages BMDP 
(version 7.1; BMDP Statistical Soft ware Inc., Los Angeles, CA) and SAS 
(versions 8.1 and 8.2; SAS Institute Inc., Cary, NC) for UNIX. Th e criteria 
for statistical signifi cance as two-sided P values are defi ned in the original 
communications. Descriptive data were presented as mean (SD), n (%) or 
median (25th and 75th percentiles).
Th e normality of variables was determined with the Shapiro-Wilk W 
test. A logarithmic, square root or reciprocal transformation was applied 
for variables with skewed distributions if a better approximation to normal 
distribution was obtained. When near-normality was not achieved, non-
parametric tests were applied or the variables were treated as categorical 
in the analyses.
Th e signifi cance of diff erences between groups in continuous variables 
was analysed with the Student’s unpaired t test, the Mann-Whitney U test 
or the analysis of covariance. Th e signifi cance of diff erences in categorical 
variables was tested with χ2 test. Partial Pearson’s product-moment correla-
tion and Spearman’s rank correlation tests were used to examine adjusted 
interrelationships between variables of interest.
Associations of dietary and plasma exposure variables with outcome 
measures of glucose metabolism were evaluated with multiple linear re-
gression analysis. Since in Studies I, II and IV the participants could be 
relatives, the analyses were performed with the PROC MIXED procedure 
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(SAS/STAT soft ware; SAS Institute Inc., Cary, NC), where the family con-
nection was considered. Potential interaction with the PPARG Pro12Ala 
polymorphism in Studies I and II was explored in models that included 
main eff ects and the product term of the genotype and the exposure vari-
able, and thereaft er in genotype-stratifi ed analyses. A statistical interaction 
exists when the degree or direction of the association of a dietary vari-
able with an outcome variable diff ers according to the genotype. If there 
was no indication of interaction, the interaction variable and the genotype 
variable were omitted from the model, and results were presented as such. 
To evaluate whether associations between exposure and outcome variables 
were independent of potential confounding factors, these were added to 
the models. Potential confounding factors were identifi ed from earlier re-
ports and from correlation analyses of the present studies.
In regression models, dietary fatty acids were expressed as proportions 
of total fatty acids similarly as plasma cholesterol ester fatty acids (Stud-
ies I and II). Otherwise, the intakes of nutrients were adjusted for energy 
intake according to the residual adjustment method (Willett and Stampfer 
1986). Measures of glucose metabolism, dietary, clinical, anthropometric 
and demographic variables, except sex and smoking, were included in the 
models primarily as continuous variables. Exceptions are outlined in the 
original publications.
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5 RESULTS
Dietary and plasma cholesterol ester fatty acids in relation to glucose 
metabolism (Studies I and II)
Several statistically signifi cant diff erences were observed between men and 
women in the intakes and plasma levels of fatty acids (Study I, Table 1 and 
Study II, Table 1). Th erefore, the analyses concerning fatty acids were per-
formed mainly separately for men and women.
Th e proportions of Pro/Pro, Pro/Ala and Ala/Ala genotypes were 75.7%, 
22.0% and 2.3%, respectively. Th e distribution of the genotypes did not 
signifi cantly deviate from Hardy-Weinberg predictions (P > 0.05). Because 
of the low number of Ala/Ala subjects (5 men and 8 women), Pro/Ala and 
Ala/Ala subjects were considered one group and compared with Pro/Pro 
subjects in the regression models studying interaction between the PPARG 
Pro12Ala polymorphism and the fatty acid exposure variables. Th e pro-
portion of plasma EPA was higher in Ala allele carrier women than in ho-
mozygote Pro/Pro women (1.67% vs. 1.44%, P = 0.006).
In men, regression models studying interaction between the PPARG 
Pro12Ala polymorphism and dietary and plasma fatty acids showed a sig-
nifi cant interaction for the intake of γ-linolenic acid (P = 0.001) and for 
plasma stearic acid (P = 0.002) on the 2-h plasma glucose concentration. In 
the genotype-stratifi ed analyses, high intake of γ-linolenic acid (regression 
coeffi  cient [SE] -1.17 [0.28], P < 0.001) and high plasma stearic acid pro-
portion (regression coeffi  cient [SE] -0.23 [0.08], P = 0.010) were associated 
with low 2-h plasma glucose in Pro/Pro men, whereas no association was 
seen in Ala allele carrier men (P = 0.12 and P = 0.22, respectively) (Study 
I, Table 3).
In women, a signifi cant interaction (P = 0.007) between the PPARG 
Pro12Ala polymorphism and dietary palmitic acid on the fasting plasma 
glucose concentration was observed. In the stratifi ed analyses, palmitic acid 
was directly related to the outcome variable in Ala allele carrier women 
(regression coeffi  cient [SE] 0.02 [0.005], P = 0.015) but not in Pro/Pro 
women (P = 0.42) (Study I, Table 3). Furthermore, in women, a signifi cant 
interaction (P = 0.008) was observed between the PPARG Pro12Ala poly-
morphism and dietary arachidonic acid on 2-h glucose levels, although in 
the stratifi ed analyses, the opposite associations in the genotype groups 
(direct in the Pro/Pro homozygous and inverse in the Ala allele carriers) 
did not reach signifi cance (P = 0.093 and P = 0.064, respectively) (Study I, 
Table 3).
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Regarding marine n–3 fatty acids, a signifi cant interaction (P = 0.036) 
was present between the PPARG Pro12Ala polymorphism and plasma 
DHA on the fasting NEFA concentration in men. Th e genotype-stratifi ed 
models showed an inverse association in Pro/Pro homozygotes (regres-
sion coeffi  cient [SE] -0.14 [0.06], P = 0.028), but not in Ala allele carriers 
(P = 0.40) (Study II, Table 2). In the stratifi ed models, also the intakes of 
fi sh (regression coeffi  cient [SE] -0.13 [0.05], P = 0.015), EPA (regression 
coeffi  cient [SE] -0.05 [0.02], P = 0.022) and DHA (regression coeffi  cient 
[SE] -0.05 [0.02], P = 0.023) showed inverse associations with this outcome 
variable in Pro/Pro men, but not in Ala allele carrier men (P ≥ 0.45) (P for 
interaction between these exposure variables and the polymorphism was 
0.10-0.12).
A signifi cant interaction between the PPARG Pro12Ala polymorphism 
and plasma EPA on insulin resistance was observed in men (P = 0.040; in 
women P for interaction was 0.12) (Study II). When men and women were 
analysed together in the stratifi ed model, a high proportion of plasma EPA 
was associated with low insulin resistance in Ala allele carriers (regression 
coeffi  cient [SE] -0.17 [0.08], P = 0.038), while no association was seen in 
the Pro/Pro genotype group (regression coeffi  cient [SE] 0.04 [0.04], P = 
0.28).
A signifi cant interaction (P = 0.020) between the PPARG Pro12Ala 
polymorphism and fi sh intake on 2-h glucose concentration was found in 
women. Genotype-stratifi ed models showed an inverse association in Ala 
allele carriers (regression coeffi  cient [SE] -0.14 [0.05], P = 0.039), but not 
in Pro/Pro homozygotes (P = 0.87) (Study II, Table 3).
Regarding the plasma surrogates of elongase and desaturase enzymes, 
in women a signifi cant interaction was observed between the PPARG 
Pro12Ala polymorphism and Δ5-desaturase on insulin resistance (P = 
0.006) and on the 2-h plasma glucose concentration (P = 0.005). In the 
genotype-stratifi ed models, inverse associations were observed in Ala al-
lele carrier women (for insulin resistance regression coeffi  cient [SE] -0.72 
[0.21], P = 0.011, and for the 2-h plasma glucose regression coeffi  cient [SE] 
-0.57 [0.13], P = 0.003), but not in Pro/Pro homozygotes (P = 0.40 and P 
= 0.62, respectively) (Study I, Table 3). In men, a signifi cant interaction (P 
= 0.007) with the PPARG polymorphism was found for Δ5-desaturase on 
the fasting plasma glucose, but the opposite associations in the genotype 
groups (direct in Pro/Pro homozygous and inverse in Ala allele carriers) 
were not signifi cant in the stratifi ed models (P = 0.14 and P = 0.16, respec-
tively) (Study I, Table 3).
A summary of the fatty acids and the surrogates of desaturase enzymes 
for which the present fi ndings found an interaction with the PPARG 
Pro12Ala polymorphism on measures of glucose and NEFA metabolism 
separately in men and women is presented in Table 1. As the results sug-
gested that several of the interactions might be sex-specifi c, formal tests 
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for interactions between sex, genotype and exposure variable on the out-
comes were performed. Th ese analyses yielded the following P values for 
the third-order interaction terms (sex * genotype * exposure): dietary pal-
mitic acid on fasting plasma glucose, P = 0.002; dietary γ-linolenic acid 
on 2-h plasma glucose, P = 0.054; dietary arachidonic acid on 2-h plasma 
glucose, P = 0.034; dietary EPA on fasting serum NEFA, P = 0.078; dietary 
DHA on fasting serum NEFA, P = 0.055, and on 2-h plasma glucose, P = 
0.15; plasma stearic acid on 2-h plasma glucose, P = 0.14; plasma EPA on 
insulin resistance, P = 0.26, and on 2-h plasma glucose, P = 0.49; plasma 
DHA on fasting serum NEFA, P = 0.049, and on 2-h plasma glucose, P = 
0.019; Δ5-desaturase on fasting plasma glucose, P = 0.28, on insulin resist-
ance, P = 0.23, and on 2-h plasma glucose, P = 0.71. Th us, according to the 
present fi ndings, an interaction between the Pro12Ala polymorphism and 
dietary palmitic acid on the fasting plasma glucose is sex-specifi c, as is that 
of dietary arachidonic acid on the 2-h plasma glucose and those of plasma 
DHA on the fasting serum NEFA and on the 2-h plasma glucose.
5 Results
In addition to the above-mentioned genotype-specifi c associations, 
high plasma dihomo-γ-linolenic acid was associated with high insulin re-
sistance (regression coeffi  cient [SE] 0.28 [0.10], P = 0.006) and with high 
2-h plasma glucose concentration (regression coeffi  cient [SE] 0.17 [0.06], 
P = 0.007) in the combined group of women (P for interaction with the 
PPARG polymorphism ≥ 0.20) (Study I).
Table 1. Fatty acids and the surrogates of desaturase enzymes for which the present 
fi ndings suggest an interaction with the PPARG Pro12Ala polymorphism on measures 
of glucose and NEFA metabolism.    
HOMA insulin 
resistance
Fasting plasma 
glucose
2-h plasma 
glucose
Fasting serum 
NEFA
Men
Dietary γ-linolenic acid ×
Dietary EPA and DHA ×
Plasma stearic acid ×
Plasma EPA ×
Plasma DHA ×
Δ5-desaturase ×
Women
Dietary palmitic acid ×
Dietary arachidonic acid ×
Dietary DHA ×
Plasma EPA × ×
Plasma DHA ×
Δ5-desaturase × ×
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Furthermore, the plasma proportion of DHA was inversely associated 
with insulin resistance in all men (regression coeffi  cient [SE] -0.13 [0.06], 
P = 0.035), and the intakes of EPA (regression coeffi  cient [SE] -0.04 [0.01], 
P = 0.006) and DHA (regression coeffi  cient [SE] -0.04 [0.01], P = 0.015) 
were inversely associated with 2-h serum NEFAs in all women.
Dietary and plasma tocopherols and carotenoids in relation to glucose 
metabolism (Study III)
Th e dietary intake of α-tocopherol was inversely associated with the fast-
ing plasma glucose concentration in women (regression coeffi  cient [SE] 
-0.54 [0.25], P = 0.032) (Study III, Table 5). In contrast, a direct association 
between plasma α-tocopherol concentration and 2-h plasma glucose lev-
els was observed in both men (regression coeffi  cient [SE] 0.39 [0.18], P = 
0.038) and women (regression coeffi  cient [SE] 0.42 [0.16], P = 0.013).
An inverse association between the intakes of α-carotene (regression 
coeffi  cient [SE] -0.07 [0.02], P = 0.005), β-carotene (regression coeffi  cient 
[SE] -0.24 [0.08], P = 0.006) and lycopene (regression coeffi  cient [SE]
-0.60 [0.14], P < 0.0001) and the fasting plasma glucose concentration was 
observed in men (Study III, Table 5). In addition, plasma β-carotene was 
inversely related to insulin resistance in men (regression coeffi  cient [SE] 
-0.28 [0.09], P = 0.003). In women, on the other hand, plasma β-carotene 
showed a direct association with the fasting plasma glucose concentration 
(regression coeffi  cient [SE] 0.25 [0.11], P = 0.026) (Study III, Table 5).
Dietary fi bre in relation to glucose metabolism (Study IV)
Th e intakes of total (regression coeffi  cient [SE] -0.17 [0.07], P = 0.012), in-
soluble (regression coeffi  cient [SE] -0.15 [0.07], P = 0.024) and soluble fi bre 
(regression coeffi  cient [SE] -0.14 [0.07], P = 0.049) were inversely related to 
insulin resistance in men and women combined (Study IV, Table 3).
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6 Discussion
6.1 Subjects and methods
Study population and study design
Th e present results should be interpreted in the light of the study popula-
tion and the study design. Th e study subjects comprised a high-risk group 
for T2D because they were all fi rst- (98%) or second-degree (2%) relatives 
of patients with diagnosed T2D. Th e subjects were thus not representative 
of the general population, and the fi ndings are not generalizable beyond 
genetically susceptible persons.
Th e rationale for studying non-diabetic relatives of patients with T2D 
was to explore a high-risk population in which, because of genetically de-
termined defects in glucose metabolism, the associations of dietary fac-
tors with glucose metabolism might be altered compared with the gen-
eral population. Subjects at high risk for T2D are characterized by many 
metabolic alterations, such as abdominal obesity, insulin resistance, im-
paired β-cell function, reduced muscle glycogen synthesis, elevated fast-
ing NEFA levels, increased intramyocellular lipid accumulation and en-
dothelial dysfunction (Vaag et al. 1995, Groop et al. 1996, Kosaka et al. 
1996, Perseghin et al. 1996, 1997, 1999, Balletshofer et al. 2000, Shulman 
2000, Kashyap et al. 2003, Petersen et al. 2004). Because of these predia-
betic derangements, the associations of nutritional factors with glucose 
metabolism could well be diff erent from those in subjects with a diff erent 
degree of genetic predisposition to the disease. Clues about diff erences 
in metabolic response between subjects with and without a family his-
tory of the disease have been observed regarding the eff ects of physical 
activity (Higgins et al. 2005). By studying relatives of patients with T2D, 
genetic heterogeneity among subjects, which might impede the fi nding 
of relevant associations, can be reduced. Studying subjects with inherited 
susceptibility but without manifest T2D is necessary when searching for 
associations between dietary factors and metabolic defects present early 
in the course of the disease. 
Th e participation rate in the study was good (81%), but a response 
bias according to the health status of the subjects was evident. Th ose who 
chose not to participate had higher glucose and insulin levels, although 
in other features (age, BMI, WHR, physical activity, length of education) 
the refusers and the participants did not diff er. Some caution is, there-
fore, necessary when interpreting the results and generalizing them to 
the original study population. Had the associations of dietary factors with 
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measures of glucose metabolism been markedly diff erent between sub-
jects who participated and those who did not, a bias would have been 
introduced.
Th e observational cross-sectional design of this study precludes infer-
ences regarding causality. Th is is especially true when interpreting results 
concerning associations of plasma nutrient levels with measures of glucose 
metabolism, as disordered glucose metabolism may aff ect plasma nutri-
ent levels (Arab 2003). However, regarding associations between dietary 
intake and, for example, insulin resistance, since the subjects were unaware 
of their insulin resistance status at the time of dietary data gathering, it is 
not unreasonable to assume that dietary factors aff ected insulin resistance 
and not vice versa.
Measurement of dietary intake
Accurate estimation of dietary intake is essential for establishing associa-
tions between nutritional factors and outcome variables (Marshall 2003). 
However, the assessment of usual diet is problematic due to large day-to-
day and seasonal variation in food intake and misreporting (Tarasuk and 
Brooker 1997, Lissner et al. 1998).
Th e purpose of dietary data gathering here was to obtain representative 
data on habitual intake of the participants using an estimated food record. 
Data from 3 recording days were used in Studies I, II and III, and data from 
6 days in Study IV. Th e strengths of food records include providing quan-
titative data and not relying on memory, but inconvenience of recording 
and socially desirable responding may lead to alteration of normal dietary 
habits. Th is may aff ect the type and quantity of foods and drinks consumed 
or reported (Th ompson and Byers 1994, Macdiarmid and Blundell 1997). 
Th e fact that intake data based on 3-day food records do not give a very 
accurate picture of the usual diet due to high intra-individual variation in 
food consumption and nutrient intake is a major limitation of this study. 
Strengths include special attention being given to checking of food records 
and the nutrient database used being continuously updated and allowing 
special recipes to be input. Of special relevance to the present study was 
that the database comprises comprehensive data on fatty acids and enabled 
also the measurement of fatty acids of minute intake levels.
Self-reported food intakes are prone to underreporting leading to un-
derestimation of energy and nutrient intakes (Lissner et al. 1998). Prob-
ability of underreporting is associated with obesity, female sex and older 
age (Heitmann and Lissner 1995, Hirvonen et al. 1997, Lissner et al. 1998, 
Livingstone and Black 2003). When studying obesity-related diseases, 
obesity-related underreporting is especially problematic, as it can lead to 
biased estimates of diet-disease relationships (Lissner et al. 1998). Selective 
overreporting of ’healthy’ foods, such as vegetables and fruits, and under-
reporting of ’unhealthy’ foods, such as cakes, sugar, candies and fats, may 
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lead to biased estimates of, e.g., macronutrient intake (Heitmann and Liss-
ner 1995, Tarasuk and Brooker 1997, Livingstone and Black 2003).
Th e relatively poor precision of dietary assessment distorts estimates 
of nutritional exposure. Oft en, it is likely to result in underestimates of 
exposure-outcome associations (Marshall 2003). Methods used to reduce 
the eff ects of underreporting include exclusion of subjects reporting low 
energy intake relative to energy requirements (Goldberg et al. 1991) and 
adjustment of nutrient intakes for energy intake (Willett and Stampfer 
1986). Excluding underreporters from the data set may lead to substantial 
loss of subjects, thus reducing the statistical power of analyses and may 
also introduce an unknown bias if only a proportion of underreporters is 
identifi ed (Macdiarmid and Blundell 1997, Lissner et al. 1998, Livingstone 
and Black 2003). Adjustment for energy intake reduces between-person 
variation in nutrient intake due to misreporting and allows all data to be 
included (Stallone et al. 1997, Willett et al. 1997, Lissner et al. 1998). Th is 
approach cannot, however, eliminate bias in nutrient intake if it is due to 
selective underreporting of, e.g., high-fat foods. Although overall under-
reporting cannot be ruled out in the present data set, selective underre-
porting of fatty foods at group level seems improbable as the proportion 
of energy from fat was high in both men and women (37.0% and 35.8%, 
respectively) compared with statistics (33.4% in men and 31.5% in women) 
reported in the Finnish National Dietary Survey FINDIET 1997 (FINDIET 
Study Group 1998).
For the above reasons, all subjects were included in the analyses, and 
nutrient intake was mainly adjusted for energy intake according to the re-
sidual method of Willett and Stampfer (1986). In Studies I and II, both 
dietary and plasma fatty acids were, however, expressed as percentage of 
total fatty acids because expression in comparable units has been recom-
mended (Connor 1996).
Biochemical indicators of dietary intake
Th e obvious limitations of self-reported dietary intake data have spurred 
the use of diff erent biochemical indicators of dietary intake, also called ’bi-
omarkers’, in epidemiological studies (Katan 1998). Th ese are more objec-
tive measures of the exposure, as they do not rely on capability to describe 
foods and are unaff ected by social desirability issues (Marshall 2003, Potis-
chman 2003). Biomarker levels are, however, not only infl uenced by dietary 
intake, but also by a number of other factors, including, but not limited to, 
absorption and metabolism of the nutrient, intake of other nutrients, age, 
sex, physical exercise, smoking, genetics and health status (Holman 1986, 
Blanck et al. 2003, Marshall 2003, Pollard et al. 2003, Potischman 2003).
Th e correlation coeffi  cients between dietary and plasma fatty acids are 
usually relatively low, and opinions about the usefulness of dietary vs. bi-
omarker fatty acid data diff er (Potischman 2003, Vessby 2003). Th e low 
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correlations are certainly partly explained by uncertainties in dietary re-
porting, but probably also by plasma fatty acid levels being infl uenced by 
factors other than the intake of fatty acid per se. Th ese include, e.g., the 
relative amounts of other fatty acids, the metabolism of fatty acids in the 
body, nutritional status, genetic factors and disease processes (Zock et al. 
1997, Arab 2003, Potischman 2003, Phinney 2005). Because two measures 
of an exposure can be mutually benefi cial by providing a wider view of the 
exposure than only one measure (Connor 1996), both dietary intake and 
fatty acid composition of plasma were used in the analyses as fatty acid 
exposure variables.
Th e fatty acid composition of plasma cholesterol esters, which was used 
here, refl ects the relative fatty acid intake during the past weeks (Ma et al. 
1995, Zock et al. 1997). Signifi cant correlations between dietary and plasma 
proportions were found for most SFAs and PUFAs, but not for oleic acid 
(Study I, Table 2), fi ndings compatible with earlier data (Zock et al. 1997). 
In general, the correlation coeffi  cients were lower in women. Whether this 
was due to dietary misreporting in women or refl ects diff erent handling or 
metabolism of fatty acids between the sexes (Luxon et al. 1998) is unclear. 
Th e fi nding of a higher proportion of DHA, but not eicosapentaenoic acid 
(EPA), in women than in men (Study II, Table 1) is in line with an earlier 
fi nding of higher cholesterol ester DHA in women (Giltay et al. 2004).
Plasma concentrations of α- and γ-tocopherol, α- and β-carotene and 
lycopene were used besides the intake of these nutrients as antioxidant ex-
posure variables. A signifi cant correlation between the dietary intake and 
plasma β-carotene was found only in women (Study III, Table 2). Earlier 
studies have reported signifi cant correlations between dietary and serum 
β-carotene in both men and women (Wallström et al. 2001), only in men 
(El-Sohemy et al. 2002) and in neither gender (Carroll et al. 1999). Th e 
degradation of β-carotene has been suggested to be the cause of the weak 
correlations oft en observed (Jandacek 2000).
A signifi cant correlation between plasma γ-tocopherol concentration 
and the intake of γ-tocopherol was found, while the plasma level of α-to-
copherol was unrelated to its intake (Study III, Table 2). Th ese fi ndings are 
compatible with those of El-Sohemy et al. (2001), suggesting that plasma 
levels provide a better biomarker of γ-tocopherol intake than of α-toco-
pherol intake. Other previous studies have yielded mixed results about the 
correlation between dietary and blood α-tocopherol levels, as summarized 
by Ford and Sowell (1999).
Relationships between dietary intake and serum levels of antioxidants 
are thus not straightforward. Correlations may be diminished because of 
daily variation both in dietary intake and in blood concentrations (Wall-
ström et al. 2001), but also due to oxidative stress if the nutrient is used as 
an antioxidant (Potischman 2003). Although some of the factors possibly 
confounding the relationships, such as smoking causing oxidative stress, 
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can be controlled statistically, others, e.g., genetic diff erences in metabo-
lism, may remain undetected, and thus, are not taken into consideration. 
Weak associations between dietary and serum antioxidants may thus indi-
cate that serum levels are aff ected more by factors other than dietary intake 
and do not refl ect diff erences in intake well. In the present study, this may 
apply to β-carotene in men and α-tocopherol in both sexes.
Measures of glucose metabolism
Th e outcome variables used to describe glucose metabolism were selected 
to represent the main metabolic features predictive of future T2D. Th ey 
included insulin resistance, β-cell function and fasting and 2-h postload 
glucose and NEFA concentrations. Th e rationale for using several outcome 
variables was spurred by the assumption that diff erent metabolic and ge-
netic abnormalities of a heterogeneous disease, such as T2D, may charac-
terize individuals (Matsuda and DeFronzo 1999). For example, in some 
subjects, the predominant defect may reside in the liver, whereas in others 
it may reside in muscle. While hepatic insulin resistance leads to exces-
sive HGP and is manifested as fasting hyperglycaemia, insulin resistance in 
muscle results in postmeal glucose intolerance. Th e focus of our analyses 
was to evaluate associations of dietary factors with markers of these diff er-
ent metabolic defects.
Th e euglycaemic hyperinsulinaemic clamp is the standard reference 
method for the study of insulin resistance (Ferrannini and Mari 1998). In 
large study populations, estimates of insulin resistance are, however, usually 
obtained with cheaper and less time-consuming methods (Monzillo and 
Hamdy 2003). In the present study, insulin resistance was determined by 
the HOMA-IR, which estimates insulin resistance from fasting glucose and 
insulin concentrations (Matthews et al. 1985, Ferrannini and Mari 1998). 
Th is method has been regarded as a suitable surrogate of insulin resistance 
in subjects with euglycaemia and even with mild diabetes (Monzillo and 
Hamdy 2003), although according to some fi ndings not necessarily in sub-
jects with abnormal fasting glucose concentrations (Tripathy et al. 2004). 
While assumptions of this technique have raised some concern, and it has 
been postulated to describe primarily hepatic insulin resistance (Matsuda 
and DeFronzo 1999), estimates of insulin resistance based on HOMA-IR 
have correlated well with those obtained with the clamp technique (Mat-
suda and DeFronzo 1999, Monzillo and Hamdy 2003). A high HOMA-IR 
has also predicted the development of T2D (Haff ner et al. 2000, Lyssenko 
et al. 2005).
Regarding β-cell function, fi rst-phase insulin secretion was the main 
object of interest in the present study. Th e early insulin release plays an 
important role in the maintenance of glucose homeostasis, and its deterio-
ration is predictive of future T2D (Lundgren et al. 1990, Lillioja et al. 1993, 
Haff ner et al. 2000, Del Prato 2003, Lyssenko et al. 2005). Th e measures 
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used were insulin secretion during the fi rst 10 min of an IVGTT and the 
insulinogenic index (IGI), which is based on glucose and insulin incre-
ments during the OGTT. Insulinogenic index has been shown to correlate 
well with fi rst-phase insulin secretion in IVGTT in subjects with NGT and 
IGT (Phillips et al. 1994, Tripathy et al. 2004). Compared with estimates 
based on IVGTT, the IGI may provide even more physiological results, 
as it takes into account the gastrointestinal contribution to insulin secre-
tion, which probably plays a role in the development of glucose intolerance 
(Holst and Gromada 2004). Of note, low values of the IGI have preceded 
the increase in fasting plasma glucose concentration (Kosaka et al. 1996) 
and have predicted the development of T2D (Haff ner et al. 2000, Lyssenko 
et al. 2005).
High fasting and 2-h post-challenge glucose and NEFA concentrations 
have predicted the deterioration of glucose tolerance in several studies 
(Saad et al. 1991, Charles et al. 1997, Edelstein et al. 1997). In an analysis 
of six prospective studies, fasting and 2-h glucose values were the most im-
portant predictors of progression from IGT to T2D (Edelstein et al. 1997). 
Furthermore, fasting glucose concentrations even within the normogly-
caemic range have been shown to be increased in the off spring of T2D 
parents compared with subjects without a family history of the disease, 
and have also predicted T2D in young men (Perseghin et al. 1999, Tirosh 
et al. 2005).
Th e glucose tolerance status of the subjects at the time of the dietary 
study was determined according to the latest WHO criteria based on an 
OGTT (Alberti and Zimmet 1998). Because of the day-to-day variation in 
the results of an OGTT, having only one test might result in misclassifi ca-
tion (Alberti and Zimmet 1998). Th erefore, the reproducibility of the clas-
sifi cation of the subjects could have been improved if the OGTT had been 
repeated, but this was not feasible because of the large number of subjects 
in the Botnia Study.
6.2 Dietary factors in relation to glucose metabolism
Th e choice of the dietary factors studied was based on earlier data suggest-
ing a role in glucose metabolism, but fi ndings have been inconsistent. Fat 
amount and composition may be major contributors in the pathogenesis 
of T2D, but data on an interaction between fat and genetic factors deter-
mining glucose metabolism are scarce. Since α- and γ-tocopherol are the 
principal vitamin E compounds in human diets and plasma, and α- and 
β-carotene and lycopene are among the predominant carotenoids (Rock et 
al. 1996), these were selected for study.
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6.2.1 Dietary and plasma cholesterol ester fatty acids
In our analyses, some of the associations observed between fatty acids and 
measures of glucose metabolism were dependent on the PPARG Pro12Ala 
polymorphism, while others were independent. Both of these fi ndings 
were expected because some of the eff ects of fatty acids on glucose me-
tabolism are likely to be mediated via PPAR-γ, as fatty acids are among its 
natural ligands, although fatty acids certainly also aff ect glucose metabo-
lism independent of PPAR-γ. Obviously, an interaction between diff erent 
polymorphisms and fatty acids is one thus far neglected factor behind the 
discrepancy in previous results concerning associations between fatty ac-
ids and glucose metabolism.
Th e analyses on associations between fatty acids and glucose metabo-
lism were performed mainly separately for men and women because fatty 
acid metabolism may be dependent on sex hormones (Lopes et al. 1991). 
Many of the fi ndings, indeed, turned out to be sex-specifi c. However, 
whether this was due to chance or methodological uncertainties or was 
a refl ection of actual diff erences in response to exposure between sexes is 
unclear. Although sex diff erences in the results concerning dietary fatty 
acids could have been due to diff erent dietary reporting between men and 
women, as social desirability issues have predicted underreporting only in 
women (Maurer et al. 2006), diff erent results concerning plasma levels of 
fatty acids cannot be explained by sex-specifi c misreporting. Furthermore, 
the processes leading to impaired glucose metabolism may diff er between 
men and women due to hormonal factors, sex dimorphism in the produc-
tion of infl ammatory cytokines and diff erences in the metabolic distur-
bances associated with insulin resistance (Wajchenberg 2000, Ding et al. 
2006, van Genugten et al. 2006, North et al. 2007). For example, men may 
be less sensitive to the antilipolytic eff ects of insulin (Mittendorfer 2005), 
and the induction of insulin resistance by elevated plasma NEFAs may be 
restricted to men (Frias et al. 2001). Gene expression mediated by PPARs 
may also be dependent on sex (Khan and Vanden Heuvel 2003).
Th e size of the study population may be regarded as too small to evalu-
ate any interaction between diet and genes. Th erefore, in addition to the 
present fi ndings, there may be other relevant interactions and PPARG gen-
otype-specifi c associations between fatty acids and glucose metabolism. As 
regards the analyses in Study I, the P value was considered signifi cant only 
when < 0.01 because of multiple testing of several fatty acids. Besides the 
interactions presented in Studies I and II, some interactions with a P value 
≥ 0.01 were detected; some of these are mentioned below.
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Fatty acids without interaction with the PPARG Pro12Ala polymorphism
Plasma dihomo-γ-linolenic acid
Of earlier observations concerning associations between fatty acids and 
glucose metabolism, those of plasma dihomo-γ-linolenic acid with insu-
lin resistance and glucose intolerance are among the most consistent and 
strongest (Vessby et al.1994a, b, Folsom et al. 1996, Lovejoy et al. 2001). 
Similarly, in the present analyses, high plasma dihomo-γ-linolenic acid 
was associated with high insulin resistance and plasma 2-h glucose levels, 
although only in women (Study I).
Th e dietary intake of dihomo-γ-linolenic acid is minimal, and its plasma 
level is dependent on formation from linoleic acid. Th erefore, the associa-
tions of high plasma dihomo-γ-linolenic acid with worsened glucose me-
tabolism have been suggested to be explained by the relationship of high 
plasma dihomo-γ-linolenic acid with low intake of linoleic acid, observed 
by Lasserre et al. (1985). According to this interpretation, low linoleic acid 
or high SFAs would be the real underlying factor leading to impairment of 
glucose metabolism (Vessby et al. 1994a). However, another explanation 
could be that high plasma dihomo-γ-linolenic acid levels are a result of 
the underlying disease process predisposing to T2D, and/or that dihomo-
γ-linolenic acid per se or its eicosanoid derivatives adversely aff ect glucose 
metabolism. Dihomo-γ-linolenic acid is a precursor of the monoenoic 
prostaglandins (Stone et al. 1979), of which prostaglandin A1 was shown 
to induce endothelial apoptosis (Erl et al. 2004). Th is might contribute to 
insulin resistance via endothelial dysfunction (Pinkney et al. 1997), which 
has previously been observed to be an associate of disordered glucose me-
tabolism (Hu and Stampfer 2003, Meigs et al. 2004).
As regards gene expression, a high level of activation was noted with 
prostaglandin A1 for PPAR-δ (Yu et al. 1995). Although PPAR-δ activation 
is associated with enhanced fatty acid burning in muscle (Grimaldi 2005), 
it has also been speculated that PPAR-δ overactivation might promote adi-
pocyte phenotype in muscle, e.g., via PPAR-γ activation (Jump and Clarke 
1999, Holst et al. 2003). Abnormal accumulation of lipids in muscle, due to 
an imbalance between fatty acid uptake and rate of oxidation especially in 
subjects with subnormal oxidative capability, has been suggested to be the 
main pathogenic mechanism behind insulin resistance (Lewis et al. 2002, 
McGarry 2002). If dihomo-γ-linolenic acid or prostaglandin A1 leads to 
muscle PPAR-δ overactivation and thereby contributes to increased in-
tramyocellular lipids, this might explain the common fi nding of a strong 
direct association between plasma dihomo-γ-linolenic acid level and dis-
ordered glucose metabolism.
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Fatty acids with interaction with the PPARG Pro12Ala polymorphism
Dietary palmitic acid
A signifi cant interaction between the PPARG Pro12Ala polymorphism and 
dietary palmitic acid on fasting plasma glucose was observed in women 
(Study I). In the genotype-stratifi ed analyses, palmitic acid was directly 
related to the outcome variable in Ala allele carrier women, but not in Pro/
Pro women. As palmitic acid is the major SFA in the diet, this fi nding is 
in line with the fi ndings of Pisabarro et al. (2004), according to which a 
high intake of SFAs was associated with glucose intolerance only in Ala 
allele carriers. In the study of Luan et al. (2001), the ratio of dietary PUFAs 
to SFAs was inversely related to the fasting insulin concentration in Ala 
allele carriers, but not in Pro/Pro homozygotes. In accordance with this, 
in the present study, dietary palmitic acid was directly related to HOMA 
insulin resistance in Ala allele carrier women (regression coeffi  cient [SE] 
0.04 [0.02], P = 0.032), but not in Pro/Pro women (regression coeffi  cient 
[SE] 0.01 [0.01], P = 0.44) (P for interaction > 0.05). Th e reasons for fi nding 
these associations in women only are at the moment unclear, but possibly 
related to hormonal factors. Also in the study of Robitaille et al. (2003), an 
interaction between the PPARG Pro12Ala polymorphism and dietary satu-
rated fat was observed in women only in the sex-stratifi ed analysis.
Th e prevailing notion concerning dietary fatty acid composition and 
glucose metabolism is that especially high intake of SFAs may be harm-
ful (Lichtenstein and Schwab 2000, Vessby 2003, World Health Organiza-
tion 2003, Steyn et al. 2004). Indeed, a direct relationship has been found 
between the intake of SFAs and increased insulin levels or insulin resist-
ance (Maron et al. 1991, Parker et al. 1993, Feskens et al. 1994, Vitelli et al. 
1996, Marshall et al. 1997), glucose levels or glucose intolerance (Feskens 
and Kromhout 1990, Salomaa et al. 1990, Færch et al. 2005) and develop-
ment of T2D (Feskens et al. 1995). Moreover, in controlled intervention 
trials, with the most reliable study design, replacement of SFAs with PUFAs 
(Summers et al. 2002) or MUFAs (Vessby et al. 2001) has improved insulin 
sensitivity, although in the latter study only when the total intake of energy 
from fat was below the study population median. Furthermore, the fatty 
acid composition in serum lipids and skeletal muscle membranes typical 
of insulin resistance and diabetes has usually been high in palmitic acid 
(Salomaa et al. 1990, Vessby et al. 1994a, b). Th is association has been in-
terpreted to be explained to a large extent by the fatty acid composition of 
the diet (Vessby 2003), although it is important to note that physical activ-
ity (Helge et al. 1999, Vessby et al. 2002), cardiorespiratory fi tness (König 
et al. 2003), intrauterine and early nutrition (Baur et al. 1998, Ozanne et al. 
1998), the background diet (Raatz et al. 2001), genetic factors (Storlien et 
al. 1996b), insulin resistance and endogenous synthesis and metabolism of 
fatty acids may also play a role (Vessby 2003).
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In contrast to the above-mentioned results, in some epidemiological 
studies, the intake of SFAs has been unrelated to insulin (Sevak et al. 1994) 
and glucose levels (Mooy et al. 1995) as well as to the development of T2D 
(Marshall et al. 1994, Salmerón et al. 2001). In a recent analysis among the 
population of the Finnish Diabetes Prevention Study, saturated fat intake 
was not independently associated with the risk of T2D (Lindström 2006). 
Th e discrepancy in the literature concerning fatty acids and glucose me-
tabolism has not received much attention, and possible underlying reasons 
seem to be unclear. Recent observations, including fi ndings from the present 
study, suggest one explanation. Interaction between fatty acids and diff erent 
polymorphisms related to glucose metabolism may play a role. Regarding 
the PPARG Pro12Ala polymorphism, it may be that a high intake of SFAs (or 
especially palmitic acid) is associated with impaired glucose metabolism (or 
especially high fasting plasma glucose) only in female Ala allele carriers; the 
genotype representing ~ 20% of the population (McCarthy 2004).
An explanation for the direct association between dietary palmitic acid 
and fasting glucose levels and insulin resistance in the Ala allele carrier but 
not in Pro/Pro women is still obscure. Among the eff ects of palmitic acid 
are induction of infl ammation in adipocytes (Ajuwon and Spurlock 2005), 
decreased fat oxidation (Kien et al. 2005), reduction in the proliferative 
capacity of β-cells and induction of their death (Maedler et al. 2001) and 
repression of insulin gene expression in the presence of high glucose (Ritz-
Laser et al. 1999). As especially the Ala allele carriers seem to be responsive 
to the amount of palmitic acid in the diet, it could be speculated that the 
high palmitic acid intake typical of Western diets might be an underly-
ing explanation for the earlier observations of impaired insulin secretion 
characterizing particularly the Ala genotype (Mori et al. 2001, Stefan et 
al. 2001). Whether the eff ect could be mediated by reduced TG synthesis, 
channelling palmitic acid to pathways leading to apoptosis (Listenberger et 
al. 2003), is an interesting although at present only a speculative option.
Plasma stearic acid
In line with an earlier fi nding by Louheranta et al. (1998), the intake of 
stearic acid was unrelated to glucose metabolism in the present study. 
Th ese fi ndings suggest that the eff ects of individual dietary SFAs on glu-
cose metabolism may diff er. Plasma stearic acid, by contrast, was directly 
related to 2-h glucose levels in the joint model for male genotype groups 
(data not shown). Th is observation is compatible with earlier fi ndings of a 
direct relationship between stearic acid levels and the risk of T2D (Vessby 
et al. 1994a, Wang et al. 2003). However, a signifi cant interaction between 
this plasma fatty acid and the PPARG Pro12Ala genotype on 2-h glucose 
levels was found (Study I), and the inverse association detected in male 
Pro/Pro homozygotes remained unchanged aft er further adjustments. An 
explanation for this observation remains to be elucidated.
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Dietary γ-linolenic acid
In men, a signifi cant interaction existed between the PPARG Pro12Ala 
polymorphism and dietary γ-linolenic acid on the 2-h plasma glucose con-
centration, and an inverse association was observed in the Pro/Pro men in 
the genotype-stratifi ed analyses (Study I). Th at γ-linolenic acid may have 
advantageous eff ects on glucose metabolism has been suggested earlier by 
experimental studies. Oil rich in γ-linolenic acid decreased serum glucose 
concentration compared with oil rich in saturated fat or a fat mixture rich 
in linoleic acid in male rats (Ide et al. 2001). Th e eff ect was suggested to 
be due to increased insulin-dependent glucose oxidation and incorpora-
tion into lipids in adipocytes. Importantly, PPAR-γ ligands, such as TZDs 
rosiglitazone and troglitazone, have been shown to increase glucose uptake 
into adipocytes and incorporation into TGs (Tafuri 1996, Mukherjee et 
al. 2000, Guan et al. 2002), which directly increase whole-body glucose 
disposal (Rangwala and Lazar 2004). In another study in male rats, γ-lino-
lenic acid reduced NEFA concentrations and body fat content, as well as fa-
cilitated fatty acid β-oxidation in the liver (Takada et al. 1994), which may 
also enhance glucose metabolism. No explanation for the inverse associa-
tion in the Pro/Pro homozygous but not in the Ala allele carrier men has 
yet emerged. Interestingly, supplementation with oil concentrate rich in 
γ-linolenic acid was shown to reduce spontaneous food intake, weight gain 
and adiposity of genetically obese (fafa) but not lean (FaFa) male Zucker 
rats (Phinney et al. 1993).
Th e fact that increasing proportions of γ-linolenic acid in serum have 
been observed according to the deterioration of glucose tolerance (Salo-
maa et al. 1990, Vessby et al. 1994a), while dietary γ-linolenic acid has been 
benefi cially associated with glucose metabolism in experimental studies as 
well as in the present study points to the importance of investigating both 
dietary and plasma/tissue fatty acids in relation to glucose metabolism.
Th e present fi ndings concerning γ-linolenic acid furthermore empha-
size the importance of investigating the intake of individual fatty acids, 
even those with absolutely minute intake levels, in addition to (or instead 
of) fatty acid intake at the group level of SFAs, MUFAs and PUFAs. Small 
diff erences in the structure of fatty acids may contribute to large diff erences 
in eff ects, e.g., through specifi c binding to nuclear receptors. Good-quality 
data on the individual fatty acid content of foods in nutrient databases are 
a prerequisite for these analyses.
Dietary arachidonic acid
In women, a signifi cant interaction was observed between the PPARG 
Pro12Ala polymorphism and dietary (Study I) as well as plasma (for inter-
action P = 0.020) arachidonic acid on 2-h glucose levels, although in the 
stratifi ed analyses, the opposite associations in the genotype groups (direct 
in the Pro/Pro homozygous and inverse in the Ala allele carriers) did not 
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reach signifi cance. Based on this fi nding, it could be argued that one expla-
nation for the earlier discrepant results concerning associations of serum 
arachidonic acid with glucose metabolism (Pelikánová et al. 1989, 2001, 
Salomaa et al. 1990, Vidgren et al. 1996; summarized by Lovejoy 1999) 
could be an interaction of arachidonic acid with the PPARG Pro12Ala 
polymorphism.
Th e mechanisms which might explain the opposite associations in the 
genotype groups are at the moment unclear. However, as arachidonic acid 
has been shown to exert eff ects that can both enhance and deteriorate glu-
cose metabolism, the fi nding is reasonable. Arachidonic acid has the po-
tential to downregulate GLUT4 in adipocytes (Tebbey et al. 1994), possibly 
via PPAR-γ (Long and Pekala 1996). On the other hand, arachidonic acid 
inhibits the expression of resistin (Haugen et al. 2005), which has been 
linked to adipose tissue and liver insulin resistance, and to increased HGP 
and glucose levels (Wolf 2004). Notably, although arachidonic acid was 
found to activate PPAR-γ only weakly, arachidonic acid metabolites, like 
eicosanoids, seem to be more eff ective (Dussault and Forman 2000).
Dietary and plasma marine n–3 fatty acids EPA and DHA and 
fi sh intake
A signifi cant interaction between the PPARG Pro12Ala polymorphism and 
plasma cholesterol ester DHA on the fasting serum NEFAs was observed in 
men (Study II). In the genotype-stratifi ed models, high plasma DHA was 
inversely associated with NEFA levels only in men homozygous for the Pro 
allele. In the stratifi ed models, also dietary EPA and DHA as well as fi sh 
intake showed similar inverse associations with this outcome variable in 
Pro/Pro men. Th us, the present fi ndings suggest benefi cial eff ects of EPA 
and DHA on NEFA levels in Pro/Pro men as well as in all women. Th e fi nd-
ings are somewhat consistent with the results of Gustafsson et al. (1998), 
according to which supplementation with marine n–3 fatty acids reduced 
serum NEFA concentrations in healthy subjects, although possible modi-
fying eff ects of genetic factors were not studied.
Benefi cial associations between marine n–3 fatty acids and insulin resist-
ance and glucose levels were observed mainly in Ala allele carriers. A high 
proportion of plasma EPA was associated with low insulin resistance in Ala 
allele carriers, while no association was seen in Pro/Pro genotype carriers 
(Study II). Furthermore, in women, a high intake of fi sh was associated with 
lower 2-h glucose concentration in Ala allele carriers, but no such associa-
tion was seen in Pro/Pro genotype carriers (Study II). Th ese observations of 
marine n–3 fatty acids being associated with NEFA levels in Pro/Pro men, 
but with insulin resistance and glucose levels in Ala allele carriers suggest 
that these fatty acids may aff ect metabolism by diff erent mechanisms in the 
genotype groups. Moreover, possible benefi cial eff ects on insulin resistance 
in the Ala allele carriers are not necessarily mediated via NEFAs.
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Overall, the present results are in accordance with some earlier observa-
tions and the prevailing notion that fi sh consumption and high intake and 
plasma/tissue concentrations of marine n–3 fatty acids may exert benefi cial 
eff ects on glucose metabolism (Feskens et al. 1991, 1995, Adler et al. 1994, 
Baur et al. 1998, Ekblond et al. 2000, Salmerón et al. 2001, Th orsdottir et al. 
2004; reviewed by Hu et al. 2001b, Mann 2002, World Health Organization 
2003 and Steyn et al. 2004). Th e present fi ndings did, however, also sug-
gest that the eff ects may be restricted to PPARG Ala allele carriers. Th ese 
fi ndings may provide one explanation for the discrepancy in earlier results 
suggesting no independent association (Salomaa et al. 1990, Borkman et 
al. 1993, Vessby et al. 1994a, b, Marshall et al. 1997, van Dam et al. 2002, 
Wang et al. 2003, Harding et al. 2004) or even a disadvantageous relation 
(Bjerregaard et al. 2000, Mori et al. 2000, Dewailly et al. 2001a, b) of marine 
n–3 fatty acids with glucose metabolism. Of note, in the KANWU study, 
a randomized controlled trial, supplementation with long-chain n–3 fatty 
acids had no eff ect on insulin resistance in the overall population (Vessby 
et al. 2001), and no interaction with the PPARG Pro12Ala polymorphism 
with respect to fasting glucose, insulin or NEFA levels was observed (Lindi 
et al. 2003), probably because of the limited number of subjects (n = 72) 
included in the latter analysis.
An explanation for the suggested diff erence in the associations between 
n–3 fatty acids and glucose metabolism between the PPARG Pro12Ala 
genotypes based on the present results is at present unclear. However, 
one mechanism might be via diff erent eff ects on the production of leptin, 
which may interfere with insulin signalling (Auwerx 1999). Reported ef-
fects of long-chain n–3 fatty acids on leptin have been mixed (Lombardo 
and Chicco 2006); both increased (Murata et al. 2000, Peyron-Caso et al. 
2002) and decreased (Jang et al. 2003) leptin expression and levels have 
been observed.
Summary
In summary, the fi ndings of the present analyses concerning especially the 
untoward associations of palmitic acid and the benefi cial associations of 
marine n–3 fatty acids with measures of glucose metabolism are in line 
with the prevailing notion that SFAs may increase and n–3 PUFAs decrease 
the risk of T2D (World Health Organization 2003, Steyn et al. 2004). Th ese 
fi ndings, however, further indicate that these associations may be depend-
ent on the PPARG Pro12Ala polymorphism and may possibly be sex-spe-
cifi c. A high intake of palmitic acid may adversely aff ect fasting glucose 
levels and insulin sensitivity, especially in Ala allele carrier women. Th e 
benefi cial eff ects of long-chain marine n–3 fatty acids on glucose metabo-
lism may also be most evident in Ala allele carriers.
Consistent with the results of Luan et al. (2001) and Pisabarro et al. 
(2004), our fi ndings suggest that Ala allele carriers may be especially re-
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sponsive to dietary fatty acids as regards glucose metabolism. In accord-
ance with this, the Pro12Ala genotype has been shown to be responsive 
to rosiglitazone treatment (Kang et al. 2005). In contrast to these fi nd-
ings, however, Robitaille et al. (2003) reported that Pro/Pro homozygotes 
seemed to be sensitive to dietary stimuli. Th ese inconsistencies stress the 
need to further study the topic.
As reaching unbiased data on dietary intake is diffi  cult, the diff erent 
associations of dietary fatty acids with glucose metabolism between the 
genotype groups could also have been due to biased dietary reporting. In 
this case, it would mean that reporting was biased according to the geno-
type group. Although this initially seems unlikely, it cannot be totally ruled 
out. Steinle et al. (2002) reported linkage to eating behaviour called disin-
hibition on chromosomal regions in proximity to genes encoding, among 
others, for PPAR-γ. Disinhibition describes loss of cognitive avoidance of 
eating to control body weight, leading to overeating.
As the diff erences in metabolic events predisposing to or protecting 
from T2D between the PPARG Pro12Ala genotypes are poorly known at 
present, it is understandable that the mechanisms explaining diff erent as-
sociations between fatty acids and diff erent outcome measures of glucose 
metabolism in these genotype groups are at the moment unclear. Th e tar-
get genes of the PPAR-γ are numerous (Auwerx 1999, Rocchi and Auw-
erx 1999, Berger and Moller 2002), and therefore the eff ects of PPAR-γ on 
glucose metabolism are likely to be complex and also dependent upon the 
particular ligand, e.g., the fatty acid involved. Th e diversity of the eff ects of 
diff erent fatty acids may be due to the subtle structural diff erences between 
fatty acids, aff ecting their affi  nity for the receptor, inducing diff erential ef-
fects on the coactivator/corepressor binding surface and infl uencing their 
potency as ligands (Kliewer et al. 1997, Khan and Vanden Heuvel 2003, 
Sampath and Ntambi 2005). Probably similarly as in the case of TZDs 
(Berger et al. 1996), the anti-diabetic eff ects of fatty acids may be propor-
tional to their binding affi  nity for PPAR-γ. In this respect, it is of interest 
that γ-linolenic acid, which was demonstrated to be one of the fatty acids 
interacting most effi  ciently with all PPARs (Xu et al. 1999), showed the 
strongest association with glucose metabolism here.
Trans fatty acids, which may adversely aff ect glucose metabolism 
(World Health Organization 2003, Parillo and Riccardi 2004, Steyn et al. 
2004), had to be excluded from the present analyses because at the time of 
the gathering of the dietary data manufacturers were reducing the use of 
partially hydrogenated oils in margarines, and no reliable trans fatty acid 
intake data could be obtained. Furthermore, only the interaction between 
the PPARG Pro12Ala polymorphism and fatty acids was investigated in 
this study. Although according to the prevailing knowledge, this polymor-
phism seems to be among the most interesting ones contributing to T2D, 
obviously there are also other polymorphisms that may have interaction 
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with fatty acids with respect to glucose metabolism. In fact, associations 
between fatty acids and glucose metabolism may turn out to be far more 
complicated than thus far understood.
Plasma surrogates of desaturase enzymes
Previous animal (Park et al. 1997) and human studies (Risérus et al. 2005) 
have provided evidence that a genetic component plays a role in determin-
ing Δ9-desaturase (or stearoyl-CoA desaturase, SCD) expression. Specifi -
cally, heterozygous PPAR-γ defi ciency has been shown to reduce expres-
sion of Δ9-desaturase (Yamauchi et al. 2001). In line with this, a tendency 
was observed in the present study for a lower Δ9-desaturase activity surro-
gate in the Ala male allele carrier than in Pro/Pro men (0.277 vs. 0.304, P = 
0.051). Interaction with a P value of 0.040 between this desaturase and the 
PPARG polymorphism on insulin resistance in men suggests also a role for 
genetic regulation. Earlier fi ndings concerning the direct associations of 
plasma palmitoleic acid levels with impaired glucose metabolism (Vessby 
et al. 2002) may thus be partly explained by the genetic regulation of Δ9-
desaturase (Kunešová et al. 2002).
Several studies have found inverse associations between the indices of 
Δ5-desaturase activity and insulin resistance and other measures of disor-
dered glucose metabolism (Salomaa et al. 1990, Borkman et al. 1993, Pan 
et al. 1995). Elevated Δ5-desaturase activity might contribute to improved 
insulin action by increasing the proportion of long-chain fatty acids in the 
membranes (Borkman et al. 1993). Th e present results concerning the as-
sociations between Δ5-desaturase and glucose metabolism are in line with 
earlier fi ndings, although the results also suggested that these associations 
may be dependent on the PPARG Pro12Ala polymorphism. Th e surrogate 
of Δ5-desaturase activity was benefi cially associated with measures of glu-
cose metabolism only in Ala allele carriers (Study I). Th ese fi ndings are 
concordant with the proposal that, in addition to sex, dietary fatty acids 
and physical activity (Andersson et al. 2002, Vessby et al. 2002, Burdge et 
al. 2003, Pawlosky et al. 2003, Nakamura and Nara 2004), genetic factors 
may contribute to determine the activity of desaturase enzymes, and thus, 
body fatty acid composition and its eff ects on glucose metabolism (Storlien 
et al. 1993, 1996b, Pan et al. 1995, Kunešová et al. 2002).
An alternative explanation for the observed associations between Δ5-
desaturase and glucose metabolism could, however, be foetal program-
ming. In rats, an inverse association between the activity of Δ5-desaturase 
and insulin resistance was seen in the off spring of a maternal low-protein 
group, but not in the control group (Ozanne et al. 1998). Th us, the relation-
ship between Δ5-desaturase and insulin resistance seems to be determined 
similarly by early nutritional deprivation and the Pro12Ala polymorphism 
of PPARG. Another similarity between the nutritionally deprived animals 
and the Ala allele carriers is a diff erence in the fatty acid composition com-
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pared with control animals or the Pro/Pro homozygotes. Th e level of do-
cosapentaenoic acid (22:5n–3), an elongation product of EPA, tended to be 
higher in the phospholipids from the low-protein animals than in control 
animals, while the plasma level of EPA was higher in the Ala allele carrier 
women than in the Pro/Pro women (plasma levels of docosapentaenoic 
acid were not determined) (Study II).
Based on the present fi ndings and earlier observations in rats, it is 
tempting to suggest that the Ala variant of PPARG and deprived early 
nutrition could lead to a similar ’metabolic milieu’, and thus, to respec-
tive programming of relationships between fatty acids and glucose me-
tabolism. In addition, the thrift y genotype may contribute to the thrift y 
phenotype. Support for the view that foetal programming could also be 
genetically determined and involve the PPARG Pro12Ala polymorphism 
comes from a study showing a direct association between reduced growth 
and disordered insulin metabolism in carriers of the Pro/Pro genotype, 
but not in Ala allele carriers (Eriksson et al. 2002). Interestingly, in one 
study in rats, fi sh oil supplementation prevented the development of ab-
normal glucose metabolism in adult off spring of rats fed a low-protein 
diet (Joshi et al. 2003). Th e authors suggested that marine n–3 fatty acids 
could thus contribute to the ’metabolic programming’ of foetal adapta-
tion to maternal undernutrition (Joshi et al. 2003). Similarly, if the en-
dogenous production of EPA is higher in Ala allele carriers, as suggested 
by the present study, this might protect this genotype from the deteriora-
tion of glucose metabolism.
6.2.2 Dietary and plasma tocopherols and carotenoids
Tocopherols
An inverse association between the dietary intake of α-tocopherol and the 
fasting plasma glucose concentration was observed in women (Study III). 
As α-tocopherol may play a role in the maintenance of endothelial func-
tion (Laight et al. 2000, Wu et al. 2005), the impairment of which charac-
terizes subjects with IFG (Vehkavaara et al. 1999), it could be speculated 
that the observed advantageous association between dietary α-tocopherol 
and the fasting plasma glucose might be mediated via enhanced endothe-
lial function.
Earlier, one prospective study found an inverse association between 
the dietary intake of γ-tocopherol and the risk of T2D (Montonen et al. 
2004), while two cross-sectional studies reported a direct relation be-
tween plasma γ-tocopherol concentration and GHb (Bates et al. 2004, 
Ford et al. 2005). In our analyses, the direct relation between plasma γ-
tocopherol and insulin resistance in men was abolished aft er adjustment 
for dietary covariates (Study III). Although the role of γ-tocopherol in 
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glucose metabolism remains unsettled, the above observations suggest 
that associations of dietary vs. plasma γ-tocopherol levels with glucose 
metabolism may diff er and both should be included in future studies.
An explanation for the direct association between plasma α-tocophe-
rol and 2-h plasma glucose levels observed in both sexes (Study III) con-
tinues to elude us. Th e fi nding is, however, in line with earlier reports 
of increased vitamin E levels in subjects with diabetes (Vatassery et al. 
1983, Caye-Vaugien et al. 1990, Krempf et al. 1991, Th ompson and Godin 
1995). In their study of 35 subjects with T2D, Krempf et al. (1991) noted 
a direct, although non-signifi cant (P = 0.07) relation between vitamin E 
concentration and GHb. Th erefore, as supplementation with vitamin E 
has not increased glucose levels in previous studies (Meydani et al. 1994, 
1998), and as the direct relation between plasma α-tocopherol and the 2-h 
plasma glucose remained signifi cant aft er adjustment for serum choles-
terol concentration in the present study, it is tempting to speculate that 
the observed association, instead of indicating that a high intake of α-
tocopherol adversely aff ects glucose levels, may suggest increased α-to-
copherol levels being due to underlying metabolic alterations in glucose 
metabolism (manifested as increased post-load glucose levels) in subjects 
predisposed to T2D. In an animal model of type 1 diabetes, vitamin E 
levels were increased in both untreated diabetic rats and in asymptomatic 
diabetes-prone animals (Behrens et al. 1984). Since insulin treatment re-
stored elevated vitamin E levels in the diabetic animals, the raised toco-
pherol concentrations seem to have been due to the diabetic state. Th e 
authors suggested that the utilization of vitamin E might be impaired in 
genetically predisposed individuals (Behrens et al. 1984). Whether that in-
terpretation has any relevance to explain the present fi nding, and whether 
the mechanism could be related to the prevention of vitamin E binding to 
cell membranes due to glycation or oxidative modifi cation of membrane 
proteins (Kunisaki et al. 1993, Traber and Packer 1995) warrants further 
attention.
Carotenoids
Th e inverse associations observed between the intake of carotenoids and 
the fasting plasma glucose concentration as well as between plasma β-caro-
tene and insulin resistance in men (Study III) are in line with earlier studies 
suggesting benefi cial associations between carotenoids and glucose metab-
olism (Ford et al. 1999, Facchini et al. 2000, Coyne et al. 2005, Czernichov 
et al. 2006). Th e reason for the lack of respective associations in women 
of the present study is unknown. Nevertheless, Wang et al. (2006) found 
no association between lycopene intake and the risk of T2D in women. In 
their study, however, the correlation between dietary and plasma lycopene 
was weak (r = 0.14), and the lack of an association may also have been due 
to the uncertainty of measuring lycopene intake.
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An explanation for the direct association between plasma β-carotene 
and the fasting plasma glucose concentration in women (Study III) is also 
unclear. Some older studies have found increased carotene levels in sub-
jects with diabetes (summarized by Abahusain et al. 1999), and thus, it 
could be argued that the present observation might be explained by in-
creased carotenoid levels due to altered pre-diabetic metabolism.
To summarize, although the present cross-sectional fi ndings suggest that 
tocopherols and carotenoids might exert some benefi cial eff ects on glucose 
metabolism, recently reported intervention studies do not support an inde-
pendent role for vitamin E supplementation (Czernichov et al. 2006, Liu et 
al. 2006) or β-carotene supplementation (Liu et al. 1999) in the prevention of 
T2D. Whether some untoward associations between plasma levels of antioxi-
dants and glucose metabolism observed in the present study are due to pre-
diabetic metabolism deserves attention. Regarding antioxidants and gene 
expression, as the chemical structure of vitamin E resembles that of TZDs, 
which are potent activators of PPAR-γ (Berger et al. 2005), some of the eff ects 
of vitamin E on glucose metabolism might be mediated via PPAR-γ activa-
tion. In addition, some evidence suggests that lycopene may aff ect the expres-
sion of PPAR-γ (Zaripheh et al. 2006). Th erefore, an interaction between the 
PPARG Pro12Ala polymorphism and the intake of vitamin E and carotenoids 
on glucose metabolism should be explored in future studies.
6.2.3 Dietary fi bre
Th e fi nding of an inverse association between dietary fi bre intake and 
insulin resistance (Study IV) is in line with the prevailing notion that 
dietary fi bre may benefi cially aff ect insulin sensitivity (Bessesen 2001). 
Of note, in our study, both soluble and insoluble fi bre was associated with 
better insulin sensitivity. On the other hand, while the intake of (insolu-
ble) fi bre has recently been associated with reduced risk of T2D in several 
prospective cohort studies (Salmerón et al. 1997a, b, Stevens et al. 2002, 
Montonen et al. 2003, Schulze et al. 2004; reviewed by Parillo and Riccardi 
2004, and Montonen 2005), and also in the Finnish Diabetes Prevention 
Study (Lindström 2006), dietary fi bre did not show independent associa-
tions with glucose levels in the present study. Th is might be explained by 
the majority of the subjects (~ 80%) having NGT. Associations of dietary 
fi bre with glucose levels may become evident only aft er deterioration of 
insulin secretion in subsequent stages of the disease.
Th e mechanisms of the observed associations of dietary fi bre with in-
sulin sensitivity cannot be inferred from the present study. Nevertheless, 
because adjustment for NEFA levels did not abolish the associations, die-
tary fi bre may aff ect insulin sensitivity also independently of NEFA release 
(McKeown and Mayer 2004).
As regards the eff ects of carbohydrates on glucose metabolism, the con-
cepts of glycaemic index and glycaemic load have recently received much 
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attention (Augustin et al. 2002, Jenkins et al. 2002, Brand-Miller 2003). Th e 
glycaemic index describes the diff erence in blood glucose response aft er 
ingestion of carbohydrates from diff erent foods (Arvidsson-Lenner et al. 
2004) and can be used to categorize carbohydrate foods as those rapidly 
absorbed and those more slowly absorbed. A high glycaemic index and a 
high glycaemic load, which is the product of the glycaemic index and the 
quantity of the carbohydrate in a food, have been associated with impaired 
glucose metabolism (Salmerón et al. 1997a, b, Hodge et al. 2004, Schulze et 
al. 2004). Th eir use in the guidance of food choices is, however, limited be-
cause they refer to glycaemic carbohydrates and not to food (Monro 2003). 
Th ey are therefore not suitable for labelling of foods (Arvidsson-Lenner 
et al. 2004). On the other hand, the concept of dietary fi bre is familiar to 
lay people, and information on the fi bre content of foods already exists on 
many packages. Th ese practical issues combined with the prevailing fairly 
strong evidence of benefi cial eff ects of dietary fi bre on glucose metabolism 
urge further use of the concept of dietary fi bre and the promotion of fi bre 
intake to prevent T2D (Bessesen 2001).
6.3 Strengths and limitations of the epidemiological 
approach used
Epidemiological studies can be regarded as ’experiments of nature of 
which the epidemiologist is a passive observer’ (Clayton and Hills 1993). 
By exploring associations between exposure and outcome variables with-
out a priori assumptions and oft en also without knowledge about possible 
mechanisms, thus far undetected associations can be found and new hy-
potheses provided (Davey Smith 2001, Sempos and Looker 2001). One of 
the obvious strengths of nutritional epidemiology is the study of associa-
tions between outcomes and realistic levels of dietary exposure as habit-
ual dietary intake is measured. In animal studies, the experimental doses 
of exposure factors are oft en very high compared with those of habitual 
intake in man, and extrapolations from animal studies to humans must 
be done with caution. Another major strength of epidemiological studies 
is exploring these associations in man. Th is eliminates doubt about the 
generalizability of results because of possible species-specifi c diff erences 
in metabolism (O’Rahilly et al. 2005). Epidemiological studies, in addi-
tion to randomized controlled trials, thus serve to explore whether fi nd-
ings of in vitro and animal studies are observed with relevant exposure 
levels in the human population.
Imprecision in the measurement of exposures, outcomes and con-
founders, as well as potentially inadequate adjustment for unknown or un-
quantifi able covariates are the main limitations of epidemiological studies. 
Possible measurement errors of the dietary data in the present study were 
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discussed in Section 6.1. Th e confounders used in the regression models 
were explained in the original papers. Th ey included several demographic, 
clinical and dietary factors known or assumed to be relevant confounders 
or mediators of the associations under investigation. Some obvious con-
founding variables, such as age, were adjusted for, although they were not 
necessarily signifi cant in all models. Th e choice of confounders is, however, 
not straightforward because prevailing knowledge of possible confounders 
may be limited or inconsistent. Smoking, for example, has been associated 
with blood carotenoid and vitamin E concentrations in some although not 
all studies (Rock et al. 1996, Clinton 1998, Ford and Sowell 1999, Rao and 
Agarwal 1999, Jandacek 2000). Th us, although in the present analyses re-
gression models were adjusted for many potential confounders, inadequate 
control for incompletely measured, unmeasured or unknown confounding 
factors that might explain some of the relationships cannot be ruled out. 
As regards adjustment for anthropometric confounders, it could be ar-
gued that inclusion of both BMI and WHR in a model is not appropri-
ate because of their high mutual correlation. However, as BMI and WHR 
measure diff erent aspects of body fatness, and as both overall obesity and 
abdominal obesity have been associated with diminished glucose disposal 
(Farin et al. 2006) and with increased risk of T2D (Wang et al. 2005), they 
could be introduced simultaneously to the models.
Avoiding overadjustment of the models is also an issue in statistical 
analyses of epidemiological studies. Th e true association between a dietary 
exposure and an outcome may be obscured if the model is controlled for 
covariates that might be on the causal pathway. For example, if obesity is 
an intermediary between dietary fat and insulin resistance, adjustment for 
BMI could underestimate the contribution of dietary fat. As dietary fatty 
acid variables in the present study remained related to measures of glucose 
metabolism aft er accounting for BMI, adjustment for this covariate was, 
however, reasonable and indicates that dietary fat may aff ect glucose me-
tabolism also independently of obesity.
Th e size of our study population was rather small for investigating an 
interaction between diet and genes. Th erefore, the possibility of false-nega-
tive results (Type 2 error) cannot be excluded. However, the number of 
participants was comparable with that in the study of Luan et al. (2001), 
which found an interaction between the same polymorphism and the ratio 
of dietary PUFAs to SFAs on BMI and fasting insulin levels. In addition, 
because of multiple testing of associations between several exposure and 
outcome variables, false-positive results (Type 1 error) cannot be excluded. 
Regarding regression models studying interaction between fatty acids and 
the Pro12Ala polymorphism on glucose metabolism in Study I, the P value 
was restricted to be signifi cant only when < 0.01, which somewhat reduced 
the possibility of false-positive results. However, it remains possible that 
the observed associations occurred by chance. Th is nevertheless seems un-
6.3 Strengths and limitations of the epidemiological approach used
66
likely for the fi ndings that agree with prior evidence from experimental re-
search, and for which a possible mechanism of action has been presented. 
Overall, congruence across the results of epidemiological and experimen-
tal studies supports the credibility of the fi ndings.
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7 Summary and Conclusions
T2D is a disease aff ecting genetically predisposed individuals with con-
tributing lifestyle factors. Compared with ancient times, current intakes of 
n–3 fatty acids, antioxidative nutrients and fi bre are low and may be poorly 
compatible with the ancient genetic constitution of man. Th is discrepancy 
may contribute to the development of multifactorial diseases such as T2D 
(Arab 2003, Simopoulos 2003, Cordain et al. 2005).
Recent studies have shown that T2D may be largely preventable by life-
style intervention (Pan et al. 1997b, Tuomilehto et al. 2001, Knowler et 
al. 2002), but it is not yet known whether effi  cient dietary modifi cations 
diff er according to the genetic susceptibility of subjects. Th erefore, in the 
present study, associations between dietary factors and measures of glu-
cose metabolism predicting T2D were examined in a high-risk population, 
i.e., in non-diabetic relatives of patients with the disease. Th e dietary fac-
tors investigated included dietary and plasma cholesterol ester fatty acids, 
carotenoids and tocopherols as well as dietary fi bre. Interactions between 
the PPARG Pro12Ala polymorphism and fatty acids on glucose metabo-
lism were also explored. Th is common polymorphism is assumed to be 
of practical signifi cance, as it plays an important role in the regulation of 
glucose metabolism (Hansen and Pedersen 2005).
Th e dietary study was part of the follow-up investigation of the Botnia 
Study, which is a prospective family study of genetic and metabolic defects 
of T2D (Groop et al. 1996). Th e study was approved by the local ethics 
committees. Inclusion criteria of the dietary study were as follows: 1) a 
fi rst- or second-degree family history of T2D, 2) an age of 20-70 years at 
the time of the Botnia baseline investigation and 3) NGT or IGT according 
to the 1985 WHO criteria (World Health Organization 1985). A consecu-
tive sample of 746 subjects was invited to participate, 603 (81%) of whom 
agreed.
Dietary intake was measured by means of two 3-day estimated food 
records spaced on average 6 months apart. In Studies I, II and III, dietary 
data were determined from the fi rst 3-day period, and in Study IV, from 
both 3-day food records. Th e fi eld work of the dietary study was carried out 
by local research staff  aft er completing an intensive training programme. 
Each 3-day recording period included two weekdays and one day of the 
weekend. Th e amount of food and drink was estimated using a booklet 
of food photographs with diff erent portion sizes (Haapa et al. 1985) or 
with household measurement units. Aft er the recording period, the food 
records were checked together with the participant by research staff . Th e 
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food intake data were analysed using the Finnish National Food Composi-
tion Database (Ovaskainen et al. 1996).
Th e medical screening included measurements of weight, height, waist 
and hip circumferences, blood pressure, and samples for serum lipids and 
for plasma cholesterol ester fatty acids, carotenoids and tocopherols. Stand-
ardized OGTT and IVGTT were performed. Data on smoking, education 
and physical activity were obtained by a structured questionnaire.
Associations of dietary and plasma exposure variables with measures of 
glucose metabolism were studied with multiple linear regression analysis. 
Th e main outcome variables were HOMA insulin resistance, β-cell func-
tion (insulinogenic index, fi rst-phase insulin secretion during IVGTT), 
and fasting and 2-h post-load (OGTT) plasma glucose and serum NEFA 
concentrations. As the participants could be relatives, the analyses were 
performed with the PROC MIXED procedure (SAS/STAT soft ware; SAS 
Institute Inc., Cary, NC), where the family connection was considered. Po-
tential interaction with the PPARG Pro12Ala polymorphism in Studies I 
and II was explored by models including the main eff ects and the product 
term of the genotype and the exposure variable, and thereaft er by perform-
ing genotype-stratifi ed analyses. To evaluate whether associations between 
exposure and outcome variables were independent of potential confound-
ing factors, these were added to the models. Potential confounders were 
identifi ed from earlier reports and from correlation analyses of the present 
studies.
Th e major fi ndings of Studies I to IV can be summarized as follows:
Study I
In men, regression models studying interaction between the PPARG 
Pro12Ala polymorphism and dietary and plasma fatty acids showed in-
teraction for the intake of γ-linolenic acid and for plasma stearic acid on 
the 2-h plasma glucose concentration. In the genotype-stratifi ed analyses, 
high intake of γ-linolenic acid and high plasma stearic acid proportion 
were associated with low 2-h plasma glucose in Pro/Pro men, whereas no 
association was seen in Ala allele carriers.
In women, an interaction between the PPARG Pro12Ala polymorphism 
and dietary palmitic acid on the fasting plasma glucose concentration was 
observed. In the stratifi ed analyses, palmitic acid was directly related to the 
outcome variable in Ala allele carriers, but not in Pro/Pro women.
In women, an interaction was also observed between the PPARG 
Pro12Ala polymorphism and dietary arachidonic acid on 2-h glucose 
levels, although in the stratifi ed analyses, the opposite associations in the 
genotype groups (direct in Pro/Pro homozygous and inverse in Ala allele 
carriers) did not reach signifi cance.
Furthermore, in women, there was an interaction between the PPARG 
Pro12Ala polymorphism and Δ5-desaturase on insulin resistance and on 
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the 2-h plasma glucose concentration; inverse associations were observed 
in Ala allele carriers, but not in Pro/Pro homozygotes.
In addition to the above-mentioned genotype-specifi c associations, 
high plasma dihomo-γ-linolenic acid was associated with high insulin re-
sistance and with high 2-h plasma glucose concentration in the combined 
group of women.
Study II
In men, an interaction was present between the PPARG Pro12Ala poly-
morphism and plasma DHA on the fasting NEFA concentration, and
genotype-stratifi ed models showed an inverse association in Pro/Pro ho-
mozygotes, but not in Ala allele carriers. In the stratifi ed models, also the 
intakes of fi sh, EPA and DHA showed inverse associations with this out-
come variable in Pro/Pro men, but not in Ala allele carriers. 
An interaction between the PPARG Pro12Ala polymorphism and 
plasma EPA on insulin resistance was observed in men (P for interaction 
in women 0.12). When men and women were analysed together in the 
stratifi ed model, a high proportion of plasma EPA was associated with low 
insulin resistance in Ala allele carriers, while no association was seen in 
Pro/Pro genotype carriers.
An interaction between the PPARG Pro12Ala polymorphism and fi sh 
intake on the 2-h glucose concentration was found in women. Genotype-
stratifi ed models showed an inverse association in Ala allele carriers, but 
not in Pro/Pro homozygotes.
Finally, the proportion of plasma EPA was higher in Ala allele carrier 
women than in female Pro/Pro homozygotes.
Study III
Th e dietary intake of α-tocopherol was inversely associated with the fasting 
plasma glucose concentration in women. By contrast, a direct association 
between plasma α-tocopherol concentration and 2-h plasma glucose levels 
was observed in both men and women.
An inverse association between the intakes of α-carotene, β-carotene 
and lycopene and the fasting plasma glucose concentration was observed 
in men. In addition, plasma β-carotene was inversely related to insulin re-
sistance in men. In women, on the other hand, plasma β-carotene showed 
a direct association with the fasting plasma glucose.
Study IV
Th e intakes of total, insoluble and soluble fi bre were inversely related to 
insulin resistance in men and women combined.
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When interpreting the present fi ndings, it should be kept in mind that 
they pertain to subjects with a family history of T2D and may not be gener-
alizable beyond the study population. Because of the observational cross-
sectional nature of the study, inferences about the cause and eff ect can-
not be made. Th e associations found require confi rmation in long-term 
prospective studies, and our hypotheses should be tested in randomized 
controlled trials.
Th e results concerning associations between dietary fi bre and insulin 
resistance are consistent with the prevailing recommendations urging in-
creased intake of fi bre to prevent T2D (Bessesen 2001, World Health Or-
ganization 2003, Parillo and Riccardi 2004, Steyn et al. 2004). Benefi cial 
associations observed between the intake of carotenoids and glucose levels 
stress that a high consumption of vegetables, fruits and berries rich in caro-
tenoids might also play a role in the prevention of T2D. Whether tocophe-
rols have an independent benefi cial association with glucose metabolism 
is questionable. Th e present fi ndings were somewhat equivocal, suggesting 
a benefi cial association for dietary α-tocopherol with fasting glucose lev-
els, but a deleterious association for plasma α-tocopherol with 2-h glucose 
levels. Importantly, recently reported intervention studies do not support 
an independent role for vitamin E in the prevention of T2D (Czernichov et 
al. 2006, Liu et al. 2006). However, interactions between antioxidative nu-
trients and genetic factors, including the PPARG Pro12Ala polymorphism, 
on glucose metabolism should be explored in future studies.
Interactions observed between the PPARG Pro12Ala polymorphism 
and fatty acids with respect to glucose metabolism imply that genetic poly-
morphisms may change the metabolic response to diet, thus infl uencing 
the risk patterns of the disease. Seemingly contradictory fi ndings of previ-
ous research may be partly explained by genetic heterogeneity within and 
between study populations. Although T2D has been assumed for a long 
time to develop as a result of an interaction between genetic and environ-
mental factors, including diet, information to support this assumption has 
just started to become available.
Based on the present fi ndings, it can be argued that a high intake of the 
main dietary SFA, palmitic acid, may be adversely associated with high 
fasting glucose levels mainly in female Ala allele carriers. Furthermore, it 
can be hypothesized that the PPARG Pro12Ala polymorphism may modify 
the metabolic response to dietary marine fat. Th e benefi cial associations 
of high fi sh consumption and high intake of marine n–3 fatty acids with 
insulin resistance and glucose levels may be restricted to (female) carriers 
of the Ala allele. In addition, the conversion of α-linolenic acid to EPA may 
be higher in female Ala allele carriers than in Pro/Pro homozygous women. 
A higher conversion rate possibly during the foetal period and in adult life 
might contribute to enhanced insulin action in Ala allele carriers.
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Among the practical implications of these results is that in future stud-
ies on diet and glucose metabolism, genetic factors, such as the PPARG 
Pro12Ala polymorphism, should be taken into account. Inclusion of ge-
netic factors in the dietary analyses may provide clues about the role of ge-
netic vs. dietary factors in determining, e.g., the metabolism of fatty acids. 
At present, it is unknown to what extent the plasma/tissue fatty acid levels 
and their relationships to glucose metabolism (e.g., those of dihomo-γ-li-
nolenic acid) are determined by dietary and other lifestyle factors and to 
what extent by genetic factors or by the underlying pathogenic process. 
Furthermore, in future studies, it is of the utmost importance to explore as-
sociations of both dietary and plasma/tissue levels of nutrients in relation 
to glucose metabolism, as diff erences may exist between these (e.g., the 
associations of dietary vs. serum γ-linolenic acid with glucose metabolism 
may diff er). Th e molecular mechanisms behind the observed associations 
also require investigation.
If the present observations concerning interactions between the PPARG 
Pro12Ala polymorphism and fatty acids on glucose metabolism are repli-
cated in other populations and with other study designs, the fi ndings have 
important implications for the prevention of T2D. If associations of fatty 
acids with glucose metabolism are modulated by the genetic makeup of an 
individual, by taking this into account the prevention of the disease may 
be enhanced. However, much additional research is needed to elucidate the 
role of diet in the aetiology of T2D. Th e study of numerous nutrient-gene 
interactions is warranted. Clearly, the last chapter of the topic ’diet in the 
aetiology of T2D’ has not yet been written.
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